The role of UBZ1 in PCNA-dependent DNA damage response by Colombin, Martina
Open Research Online
The Open University’s repository of research publications
and other research outputs
The role of UBZ1 in PCNA-dependent DNA damageresponse
Thesis
How to cite:
Colombin, Martina (2013). The role of UBZ1 in PCNA-dependent DNA damage response. PhD thesis The
Open University.
For guidance on citations see FAQs.
c© 2013 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
31 0347681 X 
1111111111 11111 Role of UBZl in PCNA Dependent 
DNA Damage Response 
Martina Colombin 
A Thesis Submitted in Fulfilment of the Requirements of the 
Faculty of Life Science of the Open University (UK) for the Degree 
of Doctor of Philosophy 
International Centre for Genetic Engineering and Biotechnology 
(ICGEB) 
Trieste, Italy 
Director of Studies: Dr. Michael Myers 
External Supervisor: Dr. Lawrence Banks 
September 2013 
't*'\TG of suBfYll.$StOr\ : 2- .se.P,EfVI E '201'1 
DAle ~ w fJ ; 14 N""'~ M e- 2.0 13 
1 Student details Your full name: MARTINA COLOMBIN , ~ ... .".. ,- . 
Personal identifier WI): B2264551 
Affiliated Research Centre.(ARC) (if applicable): ICGEB 
. Department: u-;'e; ANt) .~\o MO~ o..,LA~ .sU:e.~u:) 
JhE\sis title.: The Role ot UBZ1"ln PCNA.Dependent DNA Damage R~sponse 
,-, , . ,::.' .": -. ~.' ','. . :," :.' ',,:' : .. :"" . , 
I confirm that I ~mwilling for mythesis .to be m~de available torea:~ers by The . 
Open University Library,: and that it inay be photocopied, subject to . the 
discretion ofthe Librarian 
Signed: .... /\'¥.-:~\;; .... ;' .... G.~ . ~';; .. '.~':-': ... :.: .... ... ... ... ... , '" 
Priot name~ MARTINA,cOLOMBIN 
: date: 02/12f20 13 ODjM~~'Y'i' 
, : . ":;'~i.i "" _.".' . 
h"P'//Www.open .~c. uk/(esearcNre5earcl\..degreeSloffer.pjlcka php 2 
Britlah LIbrary 
Autilorlsatlon 
(PhD and EdD 
caridldates only) 
. ; 
The Open University has agreed that a copy of your thesis can be. made 
available 011 Iban to the"Brltish librarY Thesis Service on a voluntary basis. The 
.. 'British Ut)rary may make'the tl1esis:availablebilllne:'.' Please indicate. your 
. preference below,: . 
, ". 
~ I am willing for The Open University ta loan the British Library a copy of my 
thesis 
0R 
o I do not wish:fhe Open University.to' ioan th~ British library a copy of my 
thesis 
TABLE OF CONTENTS 
TABLE OF CONTENTS ................................................................... 1 
LIST OF TABLES ........................................................................... 3 
LIST OF FIGURES .......................................................................... 3 
ABBREVIATIONS ........................................................................... 5 
ABSTRACT ................................................................................... 1 0 
1. INTRODUCTION ........................................................................ 12 
SECTION A: DNA repair .................................................................................... 12 
1.1. Double Strand Break Repair. .......................................................................... 13 
1.1.1. Non Homologous FndJoining(NHEJ) ........................................................ I.t 
1.1.2. Homologous Recombination (HR) .............................................................. 18 
1.2. Single Strand Break Repair .............................. '" .............................. '" .......... 21 
1.2.1. Mismatch Repair (MMR) ...................................................................... 21 
1.2.2. Base Excision Repair (81:R) .................................... '" .......................... 25 
1.2.3. Nucleotide Excision Repair (NER) ................................................................ 28 
1.3. Damage Tolerance .......................................................................................... 31 
1.3.1. peNA ............................................................................................ 32 
1.3.1.1. Translesion Synthesis ...................................................................... 33 
1.3.1.2. Error Frec Pathway ......................................................................... 37 
1.3.1.3. Modification or PCNA by SUMO ......................................................... 39 
SECTI()N B: Ubiquitination .................................... '" ........................................... 41 
1.1. Ubiquitin ..................................................................................................... 41 
1.1.1. Ubiquitination Enzymes ....................................................................... .41 
1.1.2. De-ubiquitination ............................................................................... .44 
1.1.3. Types of Ubiquitination ....................................................................... .46 
1.1.4. Proteasomal Degradation ...................................................................... .49 
SECTION C: Ubiquitin Binding Domain Containing Proteins ...................................... 52 
1.1. Ubiquitin Binding Domains ............................................................................... 52 
1.2. Ubiquitin Binding Proteins ............... '" ........................................................................ 54 
1.2.1. C 1 orf124 (Spartan/DVC 1 /Ubz 1) ...................................................................... 56 
2. METHODS ................................................................................... 58 
2.1. Solutions ....................................................................................................... 58 
1 
2.2. DNA and Cloning ........................................................................................... 59 
2.2.1. Plasmids Construction ...................................................................................... 59 
2.2.2. Site Directed Mutagenesis .................. '" ........................................................... 59 
2.3. Cells Handling ........................................................................................... 61 
2.3.1. Cell Culture ....................................................................................................... 61 
2.3.2. Transfection ...................................................................................................... 61 
2.4. Protein Purification ...... '.' ............................................. '" ............... '" ......... 61 
2.4.1. Lysates Collection ............................................................................................ 61 
2.4.2. Immunoprecipitalion .......................................................................................... 62 
2.4.3. Peptide Elution ................................ '" ............................................................... 62 
2.4.4. Denaturing Tandem Affinity Purification ......................................................... 62 
2.5. Protein Visualization ..................................................................................... 63 
2.5.1. Protein Staining ................................................................................................ 63 
2.5.2. Western Blotting ......... '" ................................................................................... 63 
2.5.3. Mass Spectrometry ........................................................................................... 64 
3. AIM OF THE PROJECT ................................................................ 66 
4. RESULTS ................................................................................... 67 
4.1. Ubzl Characterization ........ , ......................................................................... 67 
4.1.1. Ubzl Post-translational Moditications ............................................................ 67 
4.1.2. Ubzl Autocleavage ............... '" ......................................................................... 75 
4.2. Ubzl Binds PCNA ........................................................................................ SO 
4.2.1. Endogenous peNA ........................................................................................... 80 
4.3. PCNA Fusion Proteins .................. '" ........................................................... S5 
4.3.1. Construction of peNA Fusion Proteins ........................................................ 85 
4.3.2. Verification of peNA Constructs ............... '" ................................................... 87 
4.4. Ubzl and Ub-PCNA Co-expression ................................. '" '" ........................ 90 
4.4.1. Ub-PCNA Expression ................................................................................... 94 
4.4.2. Ubzl Mutants and lJb-PCNA Co-expression ............... '" ................................. 96 
4.5. Role of Ubzl in DNA Damage ........................................................................ 99 
4.6. Conclusions ............................................................................................... 1 02 
5. DISCUSSION ............................................................................ 103 
5.1. Ubzl is a Novel UBZ Family Protein .............................................................. 103 
5.2. A Physical Interaction Between Ubzl and PCNA ................................................ IO7 
5.3. A Possible Role for SprT Domain .................................................................. IOS 
5.4. A Possible Role for Ub-PCNA (PI) and lJbzl ..................................................... 114 
6. BIBLIOGRAPHy ..................................................................... 118 
2 
LIST OF TABLES 
Table 1.1. Examples of DNA damages and repairs ................................................... 13 
Table 1.2. TLS polymerases ...................................................................................... 37 
Table 1.3. De-ubiquitylating enzymes ..................................................................... .45 
Table 1.4. Types of poly-ubiquitin chains ................................................................ .49 
Table 1.5. Ubiquitin binding domains ....................................................................... 54 
Table 2.1. peR cycles of site directed mutagenesis .................................................. 60 
Table 2.2. Antibodies used in this project ................................................................. 64 
Table 4.1. Ubiquitin peptides from HA-MAT-Ubzl WT and D473A purifications ........ 70 
Table 4.2. Ubiquitinated peNA from I1A-MAT-Ubzl WT and HIIIL1EI12A 
purifications ......................................................................................................................... 85 
LIST OF FIGURES 
Figure 1.1. NHEJ pathway ........................................................................................ 17 
Figure 1.2. Initial steps of HR ................................................................................... 19 
Figure 1.3. Final steps of HR .................................................................................... 21 
Figure 1.4. MMR in E.coli . ....................................................................................... 23 
Figure 1.5. Two different initial steps in Eukaryotes MMR .......................................... 25 
Figure 1.6. Initial steps of BER ................................................................................. 27 
Figure 1.7. Final steps of BER .................................................................................. 28 
Figure 1.8. Initial steps ofNER ................................................................................ 29 
Figure 1.9. Final steps ofNER. ................................................................................. 31 
Figure 1.10. peNA ubiquitination and sumoylation ................................................. 33 
Figure 1.11. Polymerases switching .......................................................................... 34 
Figure 1.12. Error free pathway ................................................................................ 38 
Figure 1.13. Two models of template switching error free pathway ............................ 39 
Figure 1.14. Ubiquitination pathway ........................................................................ 44 
Figure 1.15. General roles of DUBs ........................................................................ .46 
3 
Figure 1.16. Proteasomal degradation ...................................................................... 51 
Figure 1.17. UBZ containing proteins ...................................................................... 55 
Figure 4.1. Denaturing Tandem Affinity Purification procedure (DT AP) ..................... 68 
Figure 4.2. DTAP purifications of the HA-MAT-Ubzl WT and D473A samples ............ 69 
Figure 4.3. Ubzl WT ubiquitination ....................................................................... 71 
Figure 4.4. Ubzl ubiquitin peptides ........................................................................ 74 
Figure 4.5. Ubzl poly-ubiquitination ...................................................................... 75 
Figure 4.6. Ubzl degradation bands ........................................................................ 76 
Figure 4.7. Analysis ofHA-MAT-Ubzl cleavage products ................................... 78 
Figure 4.8. The HExH motif is required for Ubzl degradation ..................................... 80 
Figure 4.9. Ubzl co-immunoprecipitates with PCNA ............................................... 83 
Figure 4.10. HA-MA T -PCNA fusion proteins ........................................................ 87 
Figure 4.11. Verification of PCNA constructs ........................................................ 88 
Figure 4.12. PI expression activates a DNA damage signal. ................................... 89 
Figure 4.13. Co-expression ofT7-PI and Ubzl results in a loss in T7-PI immunoreactivity ..... 91 
Figure 4.14. Ubzl co-purifies with a fragment ofT7-P!. ....................................... 91 
Figure 4.15. LC-MS/MS analysis ofHA-MAT-Ubzl and T7-PCNA 
co-immunoprecipitations ............................................................. 93 
Figure 4.16. Tag-Ub-PCNA is cleaved to give rise to a 10 kDa band ......................... 94 
Figure 4.17. LC-MS/MS analysis of the 10 kDa band ofPI ..................................... 95 
Figure 4.18. LC-MS/MS analysis of the 37 kDa band ofP!. ................................. 95 
Figure 4.19. PI smear. ............................................................................................. 97 
Figure 4.20. Change in T7-PI level expression ...................................................... 99 
Figure 4.21 Level ofyH2AX upon T7-PCNA constructs and HA-MAT-Ubzl 
co-transfection ................................................................................................ 1 0 I 
Figure 5.1. Cartoon of Ubz 1 ................................................................................... 107 
Figure 5.2. SprT domain mediating Ubzl autocleavage ........................................ 11 0 
Figure 5.3 Ubzl mediating HA-MAT-Ub-PCNA cleavage .................................. 111 
Figure 5.4. HA-MAT-Ub-PCNA poly-ubiquitination with Ubzl SprT double mutant...III 
Figure 5.5. Model proposed for SprT domain role ................................................ 113 
4 
ABBREVIATIONS 
(6-4) (TT 6-4 PP) Thymine-Thymine Pyrimidine-Pyrimidone (6-4) 
AMPK AMP Activated Protein Kinase 
APC Anaphase Promoting Complex 
APE) APurinic/APrymidinic site Endonuclease) 
APIM ALKB homologue 2 PCNA Interacting Motif 
ARF Alternative Reading Frame 
ATM Ataxia Telangiectasia Mutated kinase 
A TR Ataxia Telangiectasia and Rad3-related 
A TRIP ATR-Interacting Protein 
BER Base Excision Repair 
BLM BLooM syndrome protein 
BP-G Benzo(a)pyrene adducts 
BRCA I BReast CAncer type) 
BRCA2 BReast CAncer type 2 
CAK Cdk Activating Kinase 
CANOl Cullin Associated and Neddylation Dissociated I 
CDK Cyclin Dependent Kinase 
cisPt-GG Cisplatin GG adduct 
CK2 Casein Kinase 2 
CPOs Cyclobutane Pyrimidine Dimers 
CS Cockayne Syndrome 
CTiP CtBP-Interacting Protein 
DDB DNA Damage Binding 
DNA PKcs DNA-dependent Protein Kinase Catalytic Subunit 
DNA-PK DNA-dependent Protein Kinase 
dRP Deoxy Ribose Phosphate 
DSB Double Strand Break 
DSBR Double Strand Break Repair 
DT AP Denaturing Tandem Affinity Purification 
5 
DUBs De-UBiquitinating enzymes 
E6AP E6 Associated Protein 
ECOI Establishment of COhesion protein I 
EME I Essential Meiotic Endonuclease I 
ERAD Endoplasmic Reticulum Associated Degradation 
ERCC Excision Repair Cross Complementing 
EXOI EXOnuclease I 
FEN-I Flap structure specific EndoNuclease I 
GG di-Glycine 
GGR Global Genome Repair 
HA HemAgglutinin 
hABH2 Human AlkB Homologue 2 
HAUSP Herpesvirus Associated Ubiquitin Specific Protease 
HECT Homologous to the E6-AP Carboxyl Terminus 
HHR23B Human Rad23 Homologue B 
HMGB I High Mobility Group Box I 
HMGN I High Mobility Group Nucleosome I 
HR Homologous Recombination repair 
IKK IKB Kinase 
IR Ionizing Radiation 
LC/MS Liquid Chromatography/Mass Spectrometry 
L1G I DNA Ligase I 
LP Long Patch 
LUBAC Linear UBiquitin chain Assembly Complex 
MAT Metal Affinity Tag 
MATI Menage A Trois I 
MDC I Mediatior of DNA Damage Checkpoint protein I 
MGS I Maintaining Genome Stability I 
MMR MisMatch Repair 
MRN MRE lllRAD50INBS I 
MRX MREIIIRAD50/XRS2 
6 
NEMO NF kappa B Essential MOdulator 
NER Nucleotide Excision Repair 
NHEJ Non Homologous End Joining repair 
NZF Npl4 Zinc Finger domain 
OGG I 8-0xoGuanine-DNA Glycosylase 
PARI PCNA Associated Recombination Inhibitor 
PARP-I Poly (ADP-Ribose) Polymerase I 
PCNA Proliferating Cell Nuclear Antigen 
PIP PCNA Interacting Peptide 
PNK PolyNucleotide Kinase 
PNKP PolyNucleotide Kinase/Phosphatase 
POL IV DNA polymerase IV 
POL A Polymerase A 
POL ~ Polymerase ~ 
PUA ~-Unsaturated Aldehyde dehydration Product 
RAD23 Radiation Sensitive 23 
RAP80 Receptor Associated Protein 80 
RBX Ring BoX 
RFC Replication Factor C 
RING Really Interesting New Gene E3 
RIP Receptor Interacting Protein 
RNAPII RNA Polymerase II 
ROC Ras Of Complex 
ROS Reactive Oxygen species 
RPA Replication Protein A 
SAE2 SUMO-Activating Enzyme subunit 2 
SCF Skp 1 Cullin F box protein 
SDSA Synthesis Dependent Strand Annealing 
SGS 1 Small Growth Suppressor I 
SKPI S-phase Kinase associated Protein 1 
SNM I A Sensitive to Nitrogen Mustard 1 A 
7 
SP Short Patch 
SSR Single Strand Repair 
STSs Suppressor ofT cell receptor Signaling 
TCR Transcription Coupled Repair 
TDG Thymine DNA Glycosylase 
TFIlH Transcription Factor II H 
TLS TransLesion Synthesis 
TNFRI Tumor Necrosis Factor Receptor I 
TNFa Tumor Necrosis Factor a 
TOPOlIIa Topoisomerase IlIa 
TRAF2 TNF Receptor Associated Factor 2 
TT 6-4 PP Thymine-Thymine Pyrimidine-Pyrimidone (6-4) 
UB Ubiquitin 
UBA UBiquitin Associated domain 
UBC UBiquitin Conjugating enzyme 
UBD Ubiquitin Binding Domain 
UBL UBiquitin Like domain 
UBM Ubiquitin Binding Motif 
lJBZ Ubiquitin Binding Zinc finger 
UCH-L I Ubiquitin Carboxy-terminal Hydrolase L I 
UDG Uracil-DNA Glycosylase 
UEV Ubiquitin E2 Variant 
lJIM Ubiquitin Interacting Motif domain 
USPI Ubiquitin Specific Peptidase I 
WHIP Werner Helicase Interacting Protein 
WRN Werner helicase 
XAB2 XPA Binding protein 2 
XLF XRCC4-Like Factor 
XP Xeroderma Pigmentosum 
XPA Xeroderma Pigmentosum group A 
XPB Xeroderma Pigmentosum group B 
8 
XPV Xeroderma Pigmentosum Variant 
XRCC4 X-ray Reapir Cross-Complementing protein 1 
9 
ABSTRACT 
Organisms frequently must deal with several sources of damage that can alter the 
cell's genomic material. DNA damage can be caused by exogenous agents, like radiation 
and toxins or by endogenous factors, like Reactive Oxygen Species (ROS), produced 
during normal oxygen metabolism. In order to guarantee cell survival and the transmission 
of the correct genetic information to their offspring, organisms have evolved responses to 
counteract the effects of DNA damage, which include for example, repair pathways and 
DNA damage tolerance pathways. 
In this thesis, I have focused on the poorly characterized UBZ-containing protein. 
called Ubzl. Uhzl contains an Ubiquitin Binding Zinc finger (UBZ) domain, which is only 
found in other proteins involved in DNA repair, such as polymerase 11 and K, Rad 18 and 
WHIP. Moreover, Ubzl has a PCNA Interacting Peptide (PIP), which is important for its 
interaction with the Proliferating Cell Nuclear Antigen (PCNA). Besides these two 
domains, a third domain known as the SprT domain, which is of unknown function, is also 
been found in Ubzl. Currently no other eukaryotic SprT domain containing protein has 
been characterized. The Werner Helicase Interacting Protein (WHIP), which also has a 
UBZ domain, is subjected to a UBZ domain-dependent covalent ubiquitination, known as 
coupled ubiquitination; thus, at the beginning of my work, I performed Denaturing 
Tandem Affinity Purifications (DTAP), in order to verify if Ubzl is also subjected to this 
post-translational modification. I found that Ubzl does undergo coupled ubiquitination, 
and this occurs at four sites of ubiquitination. Furthermore, I demonstrated that Ubzl 
interacts with PCNA and that mutating the UBZ domain does not disrupt binding to 
PCNA. However this mutant does not bind to modified PCNA. Additionally, to verify the 
role of the third uncharacterized SprT domain of Ubzl, I constructed the SprT domain 
mutant of Ubzl, and I found that it lost the ahility to interact with modified or unmodified 
10 
PCNA. To further characterize the UbzllPCNA interaction, I generated three constructs 
expressing PCNA either alone or fused to a mono or tetra- ubiquitin moieties. 
I found that UBZ domain of Ubzl protects the ubiquitin bound to K164 of PCNA 
from being de-ubiquitinated by the SprT domain. In fact, I showed that SprT domain acts 
as a metalloprotease, removing the ubiquitins bound to the PCNA. Moreover, the Sprt 
domain mediates the Ubzl autocleavagc, which strengthens the hypothesis that it might 
have a metalloprotease activity. 
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1. INTRODUCTION 
SECTION A: DNA Repair 
A main feature for cell survival is the maintenance of genomic integrity. However, 
many DNA modifications occur daily Cfable 1.1). As a matter of fact, the genome is 
constantly subjected to several kinds of endogenous damage. Some examples are the 
Reactive Oxygen Species (ROS), produced during the aerobic metabolism, the 
deamination of cytosines, which produces uracils, and also the incorporation of wrong 
nucleotides during the replication (Waters et aI., 2009). Many environmental agents like 
UV light, ionizing radiation, and chemicals such as adducts produced by tobacco smoke or 
generated by chemotherapeutic drugs, can lead to mutations, genomic rearrangements and 
instability. 
DNA damage is particularly dangerous during DNA replication, since this can lead 
to the collapse of the replication fork and even to the formation of double strand breaks. In 
addition, if the DNA damage is not correctly repaired, the accumulation of the lesions and 
the resulting genetic instability can eventually lead to tumorigenesis or to the death of the 
cell. 
The cellular response to DNA damage may involve activation of cell cycle 
checkpoints, DNA repair pathways and if the damage is severe, can lead to apoptosis. 
DNA repair processes are highly conserved from bacteria to mammals and during 
evolution, different DNA repair pathways have evolved, because a single pathway cannot 
handle all the different types of DNA damage that can occur. In mammals, the most 
important DNA damage repair pathways are the Nucleotide Excision Repair pathway 
(NER), the Base Excision Repair pathway (BER), the MisMatch Repair pathway (MMR), 
the Non Homologous End Joining pathway (NHEJ) and the Homologous Recombination 
12 
pathway (HR) (Table 1.1). In addition. cells have evolved a process, known as Translesion 
Synthesis (TLS) that allows them to replicate DNA past the site of the damaged DNA 
(Waters et ai., 2009). 
DNA DAMAGE CAUSES REPAIR PATHOLOGY 
DSB IR, ROS, YDJ HRlNHEJ Bloom syndromes 
Incorrect base DNA replication MMR Lynch syndromes 
Deamination, Normal cellular 
BER Cancer? 
oxidation, alkylation metabolism 
Bulky lesions UY I chemicals NER XP/Cocaine 
syndromes 
Table 1.1. Examples of DNA damages and repairs. 
1.1. Double Strand Break Repair 
Double Strand Breaks (DSBs) arc generated by several natural endogenous events 
or exogenous agents. ROS produced by cellular respiration can cause the collapse of the 
replication forks, leading to DSBs. Y(D)J recombination and meiosis can also lead to 
DSBs (Lieber et ai., 2010; Shrivastav ct aI., 2008). DSBs can also occur when the 
replication machinery encounters unrepaired lesions and the replication fork collapses 
(Saleh-Gohari et aI., 2005). External agents, such as Ionizing Radiation (IR), chemical 
agents, and UY light can produce DSB. Chemotherapeutic drugs such etoposide, which is 
a cancer-treatment drug, can also induce strand breaks in cellular DNA by trapping 
topoisomerase II at the site of DNA re-ligation (Hande, 1998; Shrivastav et aI., 2008). 
Two types of DSB repair have heen discovered. These are known as Non 
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Homologous End Joining (NHEJ) and Homologous Recombination (HR) (Figures 1.1, 1.2, 
1.3). Unlike NHEJ, HR requires a sequence to be used as a template to repair the break. 
When a DSB occurs, it is primarily detected by the direct interaction of the DNA 
ends with the MRN complex, composed of MRE 11, RAD50 and NBS 1, and this complex 
is involved in both NHEJ and HR (Maser et ai., 1997). The MRN complex is required for 
the recruitment of the Ataxia Telangiectasia Mutated kinase (A TM), while the A TR-
Interacting Protein (A TRIP) recruits the Ataxia Telangiectasia and Rad3-related protein 
(ATR) (Cortez et ai., 2001; Falck et ai., 2005; Uziel et ai., 2003). A TM and A TR 
complexes phosphorylate different proteins, including the protein kinases CHK 1 and 
CHK2, that together cooperate to induce cell cycle arrest (Gatei et ai., 2003; Jazayeri et ai., 
2006; Liu et ai., 2000; Matsuoka et ai., 2000; Zhao and Piwnica-Worms, 2001). ATM also 
phosphorylates the histone variant H2AX (Rogakou et ai., 1998). yH2AX is recognized by 
the Mediator of DNA Damage Checkpoint protein 1 (MDC 1), which is phosphorylated by 
Casein Kinase 2 (CK2). The phosphory lated MDC 1 recruits the NBS 1 subunit of the MRN 
complex and more ATM. In this way, there is an amplification of the signal, which causes 
a spread of the yH2AX phosphorylation (Lou et ai., 2006; Stucki et ai., 2005). The 
spreading signal aids in chromatin remodeling which permits the further accumulation of 
MDC1, MRN and ATR and other proteins that are involved in the double strand break 
repaIr. 
1.1.1. Non Homologous End Joining (NHEJ) 
The Non Homologous End Joining pathway consists of four main steps: recognition 
of the damage, formation of a "bridge" that brings the two DNA ends together, a 
polymerase that performs the fill-in synthesis and a ligase that seals the extremities (Figure 
1.1). In mammals, the MRE Il1RAD50/NBS 1, the DNA-dependent Protein Kinase (DNA-
PK) and the DNA ligases IV are the core of NHEJ machinery (Baumann and West, 1998; 
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Ma et ai., 2004). It is thought that MRN is the first complex that interacts with the duplex. 
The RAD50 subunit, which has a DNA binding domain, has a structural role in bridging 
the free DNA ends (Hopfner et ai., 2002). KU heterodimer is then recruited at the early 
stage of NHEJ. KU consists two subunits, KU70 and KU80, which form a ring that 
encircles the duplex on both of the free ends and can translocate along it (Mimori et ai., 
1986; Walker et ai., 2001). No enzymatic function of KU is known, but it is postulated that 
its primary function is to mark the DNA termini in order to attract specific polymerases, 
nucleases and ligases to the site of DNA damage. The Ku70/K80 heterodimer together 
with the DNA-dependent Protein Kinase Catalytic Subunit (DNA-PKcs) form a complex 
known as the DNA-PK holoenzyme. KlJ binds with great avidity the DNA ends and it 
recruits the DNA-PKcs to such sites. which is then activated (Gottlieb and Jackson, 1993; 
Suwa et ai., 1994; West et at.. 1998; Yaneva et ai., 1997; Hammarsten and Chu. 1998). In 
particular, the N-terminal region of DNA-PKcs is required for it to localize at the site of 
the DSB and to bind to the KU/DNA complex, whereas the C-terminal region possesses 
the kinase activity (Davis et ai., 2013). In vitro DNA-PKcs phosphorylates various 
substrates, such as Ku70/80, X-ray Repair Cross-Complementing protein 4 (XRCC4), 
XRCC4-Like Factor (XL F), Artemis, Werner helicase (WRN) and DNA ligase IV (Chan 
et aI., 1999; Lee et ai., 2004; Ma et ai., 2005; Wang et aI., 2004; Yannone et aI., 2001; Yu 
et aI., 2008). However the importance of these post-translational modifications in vivo have 
still to be demonstrated (Douglas et aI., 2005; Wang et aI., 2004; Yu et aI., 2008; Yu et aI., 
2003). The favourite substrate for DNA-PKcs is DNA-PKcs itself. Auto-phosphorylation 
leads to a DNA-PKcs conformational change and its subsequent decoupling from the DNA 
ends, enabling the other NIIEJ factors to reach the DNA ends (Hammel et aI., 2010; 
Uematsu et ai., 2007). 
The next step ofNHEJ repair consists of filling in the gaps between the strands and 
is carried out by DNA polymerases. Both DNA-PKcs and KU. together with the initial 
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bridging action of RAD50 subunits of MRN complex, appear to play an active role in 
tethering the two broken DNA termini together, maintaining the proximity of the DNA 
ends (Cary et a!., 1997; DeFazio et a\.. 2002; Ogiwara and Kohno, 2011). If the double 
strand ends are not complementary, the DNA strands must be processed in order to have 
ligatable DNA ends. In vertebrates, the Artemis protein is the nuclease involved in most of 
the tailoring activity during NHEl repair (Ma et a!., 2004). Artemis has intrinsic 5' to 3" 
exonuclease activity but in the presence of DNA-PKcs can also acquire a 5' and 3' 
endonuclease activity. It has been suggested that Artemis is not activated through 
phosphorylation by DNA-PKcs but that DNA-PKcs autophosphorylation causes an 
alteration of the DNA conformation that facilitates the access of Artemis to the DNA 
overhang (Goodarzi et a!., 2006; Ma et a!., 20(2). 
In S. Cerevisiae, DNA Polymerase 4 (POL IV), a member of the V-family of 
polymerases, has an important role in the fill-in synthesis at NHEl junctions (Tseng and 
Tomkinson, 2002; Wilson and Lieber, 1999). Polymerase A (POL A) is the closest 
mammalian homologue, and with Polymerase f.l (POL f.l) are associated with KU and 
Ligase IV/XRCC4 complex and are involved in the gap filling in NEHl (Fan and Wu, 
2004; Ma et a!., 2004; Mahajan et a!., 2002; Nick McElhinny et a!., 2005). It has been 
reported that POL f.l and POL A are able to add nucleotides in the presence of a 
discontinuous template, and POL f.l, unlike POL A, has the ability to replicate in a template-
independent manner, allowing the ligation of incompatible DNA termini (Gu et a!., 2007; 
Nick McElhinny et a!., 2005). 
Since DNA ligation reqUIres a 5" phosphate and a 3' hydroxyl group, 
PolyNucleotide Kinase/Phosphatase (PNKP) is recruited at this step in order to catalyze 
the phosphorylation of 5' -OH termini and for the removal of any 3' -P groups. PNKP has 
also been found to interact with XRCC4 factor (Chappell et a!., 2002; lilani et a!., 1999; 
Koch et a!., 2(04). At this point, DNA ligase IV/XRCC4 complex and XLF (also known as 
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Cemunnos) are recruited by KU at the site of damage (Nick McElhinny et ai., 2000). XLF 
stimulates the DNA ligase IVIXRCC4 complex enzymatic activity, allowing the ligation of 
incompatible and mismatched DNA ends (Ahnesorg et ai. , 2006; Tsai et ai. , 2007). 
NHEJ does not require an undamaged DNA molecule and it is able to rejoin what 
remains of the two DNA ends without using a homologous template. Although the DNA 
has been repaired, in most cases, this pathway results in the loss or addition of a few 
nucleotides at the broken DNA ends. Hence, NHEJ is considered error-prone and is 
typically associated with genomic alterations. 
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Figure 1.1. NHEJ pathway. In NH EJ, MREII recruits KU at the DSB DNA termini. KU recruits the DNA-PKcs and 
together with RAD50 bridge the DSB DNA termin i. DNA-PKcs activates Artemis 5' to 3' endonuclease activity, which 
processes the DNA DSB ends. The DNA ends are then filled and re-ligated by the polymerases and ligases activity. 
Adapted from KEGG website (http://www.genome.jp/kegg/pathway/ko/ko03450.html). 
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1.1.2. Homologous Recombination (UR) 
The fundamental differences between the NHEJ and the HR pathways are the 
requirement for a long stretch of homologous template DNA in HR (Figure 1.2). This 
homology increases the fidelity of the DSB repair. HR is mainly used during DNA 
replication in the Sand G2 phase of the cell cycle, whereas NHEJ functions throughout the 
cell cycle and is the predominant mechanism for DSBs repair during GO, Gland early S 
phase. Since HR involves copying of the missing information from an undamaged 
homologous chromosome it is considered an error free repair pathway without any loss of 
genetic information (Shrivastav et al., 2008). 
HR starts with the same recognition and processmg steps that are involved in 
NHEJ, which is the binding of MRN to the DSB (Maser et aI., 1997) (Figure 1.2). In yeast. 
the MREI1/RAD50/XRS2 (MRX) complex with SUMO-Activating Enzyme subunit 2 
(SAE2) initiates the 5' to 3' resection while EXOnuclease 1 (EXOl) and DNA2 nucleases 
with the Small Growth Suppressor I (S(;S I) form long ssDNA (Gravel et aI., 2008; 
Mimitou and Symington, 2008; Zhu et aL 2008). The human orthologous of the MRX 
complex, the MREII/RAD50INBS 1 (MRN) with CtBP-Interacting Protein (CtIP) are 
important for the initial resection step, while EXOI and BLooM syndrome protein (BLM) 
together perform the resection (Gravel et a!., 2008; Jazayeri et aI., 2006; Sartori et al., 
2007). 
Cyclin Dependent Kinase (CDK) phosphorylates CtIP that is recognized by 
BRCA 1, which in turn ubiquitinates CtIP, stimulating its association with the site of DNA 
damage (Yu et aI., 2006). Resection is made in the 5'-3' direction and results in a 3' end 
overhang that is bound by Replication Protein A (RPA), which serves to protect the 
ssDNA from further damage. To initate the IIR repair, RAD51 must be assembled on the 
single stranded filament. RAD55/RAD57 complex and RAD52 have been found to act as a 
recombinase mediators; in particular, they recruit RAD51, which displaces RP A from 
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ssDNA (Sung, 1997; Sugiyama and Kowalczykowski 2002). Also the BReast CAncer type 
2 (BRCA2) has been found to act as a recombinase mediator by stimulating the binding of 
RADSI to ssDNA in its ATP-bound form, preventing the binding of RADSI to dsDNA 
(Carreira et aI. , 2009). The 3'end-RADSI nucleoprotein filament then "searches" on the 
sister chromatid for a homologous repair template and it then invades the homologous 
sequence forming a D-Ioop structure. RADS4 stabilizes the RADSI nucleo-filament that in 
turn stimulates RADS4's ATPase activity, which is important for the chromatin 
remodelling during the strand invasion (Alexeev et aI. , 2003; Mazin et aI. , 2003; Wolner 
and Peterson, 200S). 
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Figure 1.2. Initial steps of HR. In HR the MRN together with CtiP, EXO 1, BLM resect the 5' ends at the DSB and the 
3' ends are bound by the RPA proteins. RPA is then displaced and RAD5 l is assembled on the 3' ends. RAD54 forms a 
complex with RAD5l and faci litates strand invasion and homology search. Adapted from (Sung and Klein, 2006). 
In yeast, it has been reported that RADS4 stimulates heteroduplex extension and 
that both RADS4 and RADSI ATPases activities are required for the disassembly of the 
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RAD51 nucleoprotein filament from the DNA overhang, in order to allow DNA synthesis 
machinery to reach the 3' end, whereas in higher eukaryotes, the RECQ helicases like 
BLM, perform this function (Bugreev et aI., 2007; Li et aI., 2007; Solinger and Heyer, 
2001; Solinger et aI., 2002). 
At this point, two different HR processes known as Synthesis Dependent Strand 
Annealing (SDSA) and the Double Strand Break Repair (DSBR) sub-pathways can take 
place (Figure 1.3). In the SDSA process, the elongated 3' end is displaced out of the 0-
loop thus allowing it to re-anneal the DSB ends together through the newly synthesized 
complementary region. In DSBR the 3' overhang anneals to the other double strand when it 
is still part of the D-Ioop, thus creating a Holliday junction with the homologous 
chromosome (Sung and Klein, 2006). Depending on the way in which the Holliday 
junctions are resolved, this process can result in either a non-crossover or crossover gene 
conversion product. Examples of tactors involved in the resolution of the Holliday 
junctions are the endonuclease GEN I and MUS811 Essential Meiotic Endonuclease I 
(EME I) and the BLM helicase that operates together with Topoisomerase IlIa (TOPOIIIa) 
(Boddy et aI., 2001; Fekairi et aI., 2009; Ip et aI., 2008; Wu and Hickson, 2003). 
Therefore HR requires the sister chromatids to be in close proximity, which is more 
likely to occur in late Sand G2 of the cell cycle. 
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Figure 1.3. Final steps of HR. In HR the 3 'overhang searches for the homology and invades the region in the duplex to 
form a (D)-loop structure, In the DSBR sub-pathway, after DNA synthesis, the second overhang also invades the other 
strand forming a Holliday junction with the homologous chromosome, Holliday junctions may be resolved by GENI , 
MUSSI , EME I, and BLMffOPlI1. Depending on the site of the cleavage, different product may be generated with or 
without crossover of the parental chromosomes, In the SDSA sub-pathway the elongated 3' overhang is displaced and re-
annealed with the 5' end, Adapted from (Sung and Klein, 2006), 
1.2. Single Strand Break Repair 
1.2.1. Mismatch Repair (MMR) 
Base mispairing that occurs during DNA replication and recombination can lead to 
genetic errors. Mismatch Repair pathway (MMR) is able to recognize and repair this 
mispairings, as well as short insertions and deletions; it is therefore an important 
contributor for genome maintenance. In fact, if DNA damage is not repaired, it can 
generate mutations leading to diseases. MMR prevents mutations by correcting the 
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mismatches that can arise during DNA replication (Li, 2008). Inactivation of the MMR 
system has been associated with several human cancers, such as Lynch syndrome diseases 
(Bonadona et a\., 201 I; Lynch and de la Chapelle, 1999). 
The best-characterized MMR system is in E.coli, where the MUTS homodimer 
recognizes mismatched bases (Su and Modrich, 1986) (Figure 1.4). The E.coli MMR 
system is able to recognize the newly synthesized DNA strand, thanks to the methylation 
on the template strand, thereby directing the repair machinery to the newly synthetized 
unmethylated strand. MUTL stabilizes the complex between MUTS and DNA and actives 
the MUTH restriction endonuclease, which incises the unmethylated GA TC sites (Grilley 
et a\., 1989; Welsh et a\., 1987). In E.co/i the nick corresponds to the site where excision of 
the strand starts. The damaged strand is displaced by DNA helicase II and exonucleases 
(different are uses according to the strand break position) (Burdett et a\., 2001; Dao and 
Modrich, 1998; Runyon et a\., 1990; Viswanathan and Lovett, 1998). A new strand is 
synthesized to till the gap by DNA polymerase III. Finally the strands are closed by DNA 
ligase (Lahue et a\., 1989). 
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Figure 1.4. MMR in E.Coli. Mismatch is recognized by MUTS and MUTL and then incised by MUTH, which is able to 
recognize the new unmethylated DNA strand (GATe site), The mismatch is then removed by four exonucleases and new 
DNA strand is re-synthetized by polymerase III. Adapted from KEGG website (hUp://www.genome.jpikegg-
bin/show yathway?ko03430), 
In eukaryotes, the site of the mismatch is recognized by two heterodimers: MUTSa, 
which is composed of MSH2 and MSH6 subunits, and MUTS~, which is composed of 
MSH2 and MSH3 subunits (Alani, 1996; Palombo et aI. , 1995) (Figure 1.5), MUTSa, is 
responsible for the recognition of base-base mismatches, including the insertion/deletion of 
one or two unpaired nucleotides, but is also capable of recognition of larger 
insertion/deletion with lower affinity. Instead, insertions/deletions from 2 to 8-10 mispairs 
are detected by MUTS~ (Genschel et aI. , 1998). 
For subsequent steps, the MUTLa heterodimer (MLH1/PMS2) is recruited and the 
strand that contains the mismatch is excised. In mammals, two different excision systems 
have been proposed to take place depending on where the nick in the newly synthetized 
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DNA strand is situated. In fact, the exonuclease EXOI is able to degrade DNA only in a 5' 
to 3' direction; if the nick is close to the 5' end of strand, the exonuclease activity can 
proceed toward the 3' end, whereas when the nick is situated close the 3' end, the PMS2 
subunit of MUTLa, which also possesses an endonuclease activity, is activated in a 
MUTSa, Replication Factor C (RFC), the Proliferating Cell Nuclear Antigen (PCNA), and 
A TP-dependent manner and it introduces another single strand break in the strand opposite 
of the mismatch. EXOI is then able to carry out its 5'-3' activity (Genschel et aI., 2002; 
Dzantiev et aI., 2004; Kadyrov et aI., 2006). MUTSa has been reported to activate the 5'to 
3' activity ofEXOl (Genschel et aI., 2002). 
Other proteins, like the single strand DNA binding protein RPA, the High Mobility 
Group Box 1 (HMGBl) protein and reNA also play important roles in MMR. RPA and 
HMGB 1 together stimulate EXO 1 MUTSo.-activated excision, but RPA has a role also in 
the MUTLa-dependent suppressing EXO I-excision activity upon mismatch removal 
(Zhang et aI., 2005). PCNA has a role in the early steps of MMR (Umar et aI., 1996). In 
fact it has been found to interact with MUTSo. and MUTSP, but also weakly with MUTLa 
via their PCNA binding motif (Clark et aL 2000; Kleczkowska et aI., 2001; Lee and Alani, 
2006). PCNA is also thought to play a role in the later steps of MMR acting has a 
processivity factor during DNA re-synthesis (Gu et aI., 1998). 
Finally, the gap is filled by the DNA polymerase 8 and then DNA ligase I closes 
the nicks between the strands (Zhang et aL 2005). 
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Figure I.S. Two different initial steps in Eukaryotes MMR. When the nick is located close to the 5' tennini, 5'-3 ' 
EXO I exonuclease activity takes place, If the nick is situated close to the 3' tennini, another DNA nick is produced by 
MUTLa, At this point, EXO I is able to perfonn its activity, Adapted from KEGG website (http://www.genome.jplkegg-
bin/show -pathway?ko03430), 
1.2.2. Base Excision Repair (BER) 
DNA hydrolysis can cause the formation of abasic sites and deamination reactions 
can lead to the conversion of one base with another, such as a cytosine to uracil. ROS that 
arise from aerobic metabolism leads to many types of modification, such as the formation 
of 8-hydroxyguanine. BER pathway is involved in the repair of most of these endogenous 
DNA lesions and it is characterized by five steps (Figures 1.6, 1.7). These are the 
recognition of the base and its excision, the removal of the abasic site, the modification of 
the DNA break ends, the filling of the gap and the ligation of the two DNA ends (Nemec et 
aI., 2010). 
BER starts with the excision of a damaged base by a DNA glycosylase (Figure 1.6). 
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Each glycosylase, which can be mono-functional like the Thymine DNA Glycosylase 
(TDG) or bi-functional, like the endonuclease NTH I is damage specific. Mono-functional 
glycosylases require the action of AP APurinic/ APyrimidinic site Endonuclease 1 (APE 1) 
that cleaves the abasic site leaving a 3'-OH and a 5'-DeoxyRibose Phosphate (5'-dRP), 
whereas the bi-functional glycosylases also have an AP lyase activity, leading to the 
formation of a 3' -u, ~-Unsaturated Aldehyde dehydration Product (3' -PUA) of the 
deoxyribose phosphate or a 3'phosphate (3'-P), both with a 5'-phosphate (5'-P) termini 
(Nemec et ai., 20 I 0). 
Uracil DNA Glycosylase (UDe;) and TOG glycosylases are mono-functional and 
are involved in removing mutagenic uracil and thymine bases which are products of 
Cytosine and 5-methyl Cytosine deamination respectively (Lindahl, 1974; Neddermann 
and Jiricny, 1993, 1994). Bifunctional glycosylases, such as the 8-0xoGuanine-DNA 
Glycosilase (OGG I), the NEILs family and NTH I are specific for oxidized bases, such as 
8-oxo-guanine (Bandaru et ai., 2002; Hazra et ai., 2002; Matsumoto et ai., 200 I; van der 
Kemp et ai., 1996). 
The two ends of the break must be modified in order to produce a 3' -OH and 5'-P 
break end. In particular, the 5' -dRP processing is carried on by polymerase ~ (Matsumoto 
and Kim, 1995; Prasad et ai., 1998), while the 3' -PlJA and the 3' -P are modified by APE I 
and PolyNucleotide Kinase/Phosphatase (PNKP) respectively (Das et aL 2006; Suh et ai., 
1997; Wiederhold et ai., 2004). 
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Figure 1.6. Initial steps of BER. BER starts with the removal of the damaged base by a DNA glycosy lase. 
Monofunctional glycosy lases like UDG and TDG requi re the action of APE I endonuclease that cleaves the abasic site, 
leaving a 3' -OH and a 5' -dRP ends, 5' -dRP end is then modified by POL~, in order to produce a 5' -P end. Bi functional 
glycosy lases, such as OGG I and NEILs posses also the abasic site lyase activity, leaving a 5' -P and a 3' -PUA or 3' P-
ends. 3' -PUA and 3' -P are modified by the action of APE I and PNKP, Adapted from (Hegde et a!., 2008). 
At this level, two different sub-pathways of BER, named Short Patch (SP) and 
Long Patch (LP) repair may be activated according to the type of lesion (Frosina et aI. , 
1996) (Figure 1.7). In the SP repair, a single nucleotide is removed and then repaired 
through a reaction catalysed mainly by the DNA polymerase ~, which adds one nucleotide 
to the 3' end of the nick (Sobol et aI. , 1996). At the last step, XRCCI and the ligase Ligase 
lIla are required for the sealing of the nick (Cappelli et aI. , 1997). The LP BER, which 
results in the replacement of approximately 2-10 nucleotides including the damaged base, 
occurs when polymerase ~ is not able to remove the 5' -dRP lesion. The filling of the gap 
requires the DNA polymerases 8, I> and ~ (Harrigan et aI. , 2003; Prasad et aI. , 2001 ; Stucki 
et aI. , 1998). WRN, together with Poly (ADP-Ribose) Polymerase 1 (PARP1) and Flap 
structure-specific EndoNuclease 1 (FEN1) stimulate DNA polymerase ~ 5' -dRP strand 
displacement and flap DNA substrate is excised by the FENI flap nuclease activity and at 
a final step, DNA Ligase I (LIG I) ligates the DNA termini (Prasad et aI. , 2000; Harrigan 
et aI., 2003; Klungland and Lindahl, 1997; Prasad et aI. , 2001). 
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Figure 1.7. Final steps of BER. Long Patch (LP) repair and Short Patch (SP) repair are rapresented, The LP repair 
occurs when POL 13 does not remove 5'-dRP lesions. At this point, POL 8, E and 13 together fill the gap between the two 
DNA termini, displacing the 5' -dRP of 2- \0 nucleotides, FEN I together with WRN promote the strand displacement and 
excision, In the SP repair, a single nucleotide is removed and POL p adds a nucleotide at the 3' -OH end, The final gaps 
for SP and LP are the same and consist of the ligation of the DNA termini, by L1GI and L1GIIIIXRCCI , respectively. 
Adapted from (Hegde et a!. , 2008). 
1.2.3. Nucleotide Excision Repair (NER) 
The NER system is able to repair different types of damage; in fact it recognizes the 
distortion caused by the lesion in the DNA double helix (Figure 1.8). NER is related to 
BER, but the NER system is used when the modification of the bases is larger (2-30 
nucleotides) and/or causes a distortion in the double helix due to, for example, the 
formation of thymine dimers. Two sub-pathways characterize NER, the Global Genome 
Repair (GGR), which repairs the lesions over the entire genome and the Transcription-
Coupled Repair (TCR), which has the role of repairing the lesions that block the 
transcription (Figure 1.8). GGR and TCR are similar except for the initial recognition step 
ofthe DNA damage. 
The NER pathway involves several · disorders, including Xeroderma Pigmentosum 
(XP) (from XPA to XPG type), which is characterized by increased UV sensitivity and 
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people are at a high risk for developing skin cancer, such as basal cell carcinoma (Epstein 
et aI., 1970) and Cockayne Syndrome (CS), which is an is an autosomal recessive 
neurodegenerative disorder, is also characterized by photosensitivity and premature aging 
(Nance and Berry, 1992; Henning et aI., 1995; Troelstra et aI., 1992). XP can result in 
defects to both pathways, whereas CS results in defects only in TCR and is caused by 
mutation of the CSB and CSA genes. 
GGR TCR 
RECOG ITIO STEP 
Figure 1.8. Initial steps of NER. Here two two recognition steps are rapresented. [n GGR sub-pathway, the helix 
distorting lesion is recognized by a complex formed by XPC, HHR23B and Centrin2 and by DDB complex. In TCR the 
RNA POLII is blocked when encounters a DNA damage and CSB is recruited at the damaged site. Subsequently, p300, 
CSA, XAB2, HMGN I and TFIIS factors are recruited to remodel the chromatin. Adapted from (Kami[eri et aI. , 20 (2). 
In GGR, the complex formed by XPC, Human Rad23 Homologue B (HHR23B) 
and Centrin 2 has the task of recognizing the helix distorting lesion (Araki et aI., 2001; 
Batty et aI., 2000; Sugasawa et aI., 1998; Sugasawa et aI., 2001) (Figure 1.8). Since the 
XPC complex is not able to recognize small structural perturbations to the DNA, such as 
Cyc10butane Pyrimidine Dimers (CPDs), another complex called the DNA Damage 
Binding (DDB) complex, is involved in this reaction (Fitch et aI. , 2003). This complex is 
formed by two subunits, known as DDBI and DDB2IXPE. The latter has been found to 
have a high affinity for several DNA lesions, CPD dimers in particular (Wittschieben et aI., 
2005). 
29 
At the pre-InCISIOn step, another factor, known as Transcription Factor II H 
(TFIIH), is recruited by XPC (Y okoi et ai., 2000) (Figure 1.9). The TFIIH core contains 
the subunits XPB, XPD, p62, p52, p44, p34, and p8/TTD-A, which are coupled to a Cdk-
Activating Kinase complex (CAK). The two helicases XPB and XPD of the TFIIH 
complex unwind the DNA at the site of damage (Coin et ai., 2007). CAK, which has been 
found to inhibit the XPD DNA unwinding activity, is released from the TFIIH complex by 
the XPA enzymatic activity (Coin et al.. 2008; Sandrock and Egly, 2001). At this point, 
RPA binds the undamaged strand of the DNA, maintaining the open helix around the 
region of damage and it has a role in correct positioning of XPF/Excision Repair Cross 
Complementing (ERCCl) complex and XPG endonucleases, which act in the subsequent 
steps (de Laat et ai., 1998). The damaged strand is nicked at the 5' side of the damage by 
the XPF/ERCCI complex and by XPG at the 3' side (O'Donovan et aI., 1994; Matsunaga 
et aI., 1995). A polymerase and ligase together have the task of filling and mending the 
gap. It is assumed that not only polymerases 8 and £ are involved in this process but also 
the translesion polymerase K (Ogi et aI., 20 I 0). 
The repair steps of TCR-NER are similar to those of GGR-NER, but in case of 
TCR, the signal for the repair is the hlockage of transcription elongation by RNA 
Polymerase II (RNAPII) upon lesion formation (Figure 1.8). It has been demonstrated that 
CSB is the key factor in TC-NER. A stahle RNAPIIICSB complex is assemhled and then 
the other pre-incision and incision factors, which are shared with the GGR pathway, bind 
to this complex (Fousteri et ai., 2006; Tantin et ai., 1997). CSB is also required for the 
recruitment of the histone deacetylase P300 to the stalled polymerase and the CSA. CSA 
recruits additional TC-NER specific factors such as the High Mobility Group Nucleosome 
1 (HMGN 1), which is a chromatin remodeling factor, the transcription elongation factor 
TFIIS and the pre-mRNA splicing factor XPA Binding protein 2 (XAB2) (Fousteri et ai., 
20(6). HMGN 1, together with p300, play a role in chromatin remodeling, facilitating 
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access to the DNA (Birger et aI., 2003; Fousteri et aI., 2006). One other function of CSB 
may be to remove RNAPII from the damage site, so the repair can take place (Tijsterman 
and Brouwer, 1999). 
When the chromatin is in a more open form, the NER core is able to carry out the 
repair (Figure 1.9). 
PRE- INCISION COMPLEX 
DNA UNWIND 
DNA EXCISION 
DNA REPLICATION 
Figure 1.9. Final steps of NER. At the pre-incision step TFIIH complex is recruited. XPB and XPD subunits of TFIIH 
complex unwind the DNA at the site of the damage. RPA binds the undamaged strand and positionates XPG and 
XPFfERCC I endonucleases that nick the damaged strand. Polymerase Ii,E and K are involved in the gap filling. Adapted 
from (Kami leri et aI., 2012). 
1.3. Damage Tolerance 
During S phase of the cell cycle, the promotion of the completion of DNA 
replication rather than protecting the accuracy of the genomic information is preferred. 
Therefore, cells have evolved schemes to ensure continuation of DNA synthesis in the 
presence of damage, using a mechanism known as damage tolerance. In this case it is 
possible to bypass the lesion. Since this pathway does not remove the lesion from the 
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DNA, it results in mutations. 
Two pathways of DNA damage tolerance have been described, known as the error 
prone DNA TransLesion Synthesis (TLS) and the Error Free lesion bypass (Figure 1.11, 
1.12). Recent studies have described how the ubiquitination of PCNA plays an important 
role in coordinating DNA replication and the DNA damage tolerance process (Strzalka and 
Ziemienowicz, 2011) (Figure 1.10). 
1.3.1. peNA 
PCNA is a homo-trimeric ring-shaped protein, which acts as a processivity factor 
for DNA polymerases in eukaryotic cells (Prelich et aI., 1987) (Figure 1.10). Each 
monomer contains two similar domains, connected by an inter-domain connecting loop; in 
this way PCNA has six repeating domains and exhibits six-fold symmetry. The inner part 
of PCNA is rich in Lysine and Arginine residues thus permitting PCNA to encircle the 
negatively charged DNA as a ring. This special shape gives it the capacity to act as a 
clamp around the DNA (Krishna et aI., 1994). 
Three different peptide sequences have been found which permit other proteins to 
interact with PCNA: the PCNA Interacting Peptide (PIP) is contained in DNA polymerase 
Tj, K and P21 (Haracska et aI., 2001; Haracska et aI., 2002; Warbrick et aI., 1995), the KA 
box in polymerase E, 8 and RFC (Xu et aI., 2001) and the ALKB homologue 2 PCNA-
Interacting Motif (APIM), has been characterized in Human AlkB Homologue-2 (hABH2) 
protein (Gilljam et aI., 2009). Therefore, PCNA acts as a scaffold to tether proteins to the 
DNA. When PCNA tethers a polymerase to the DNA, it acts as a processivity factor by 
keeping the polymerase associated with the DNA. 
At the beginning of DNA replication. polymerase-a/primase synthetizes the first 
RNA/DNA primer on the strand. The chaperone-like RFC complex recognizes the RNA 
primer terminus along the DNA and loads peNA onto the double stranded region (Podust 
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et aI., 1995). Polymerases together with PCNA perform the DNA synthesis. In particular, 
the elongation of the leading strand is mediated by polymerase (l and polymerase E, 
whereas polymerase (l and 0 conduct the elongation of the lagging strand (Garg and 
Burgers, 2005). 
If the replication machinery encounters DNA damage, DNA replicative 
polymerases do not have the capacity to bypass the lesion and the replication fork stalls. It 
has been shown that after DNA damage, PCNA can be either mono-ubiquitinated or poly-
ubiquitinated (Hoege et aI. , 2002) (Figure 1.10). The ubiquitination and de-ubiquitination 
process will be discussed later. 
~ RAD6IRAD18 
SUMO 
K I27 
K I64 
UBA2IAOS I 
UBC9 
SIZI 
UBC I3IMMS2lRA D5 
ubiquitin 
SUMO 
UBIQUITrNATlO 
SUMOYLATIO 
Figure 1.10. peNA ubiquitination and sumoyIation. peNA can be modified by either ubiquitin at KI64 or SUMO at 
KI64 and K127. Both modifications take place during S phase of cell cycle. Mono-ubiqutination recruits TLS 
polymerases, whereas poly-ubiquitinatated peNA is recognized by an unknown factor, leading to an error free pathway. 
peNA sumoylation appears to recruits anti-recombinase proteins in order to avoid unnecessary homologous 
recombination. Adapted from (Hoege et aI. , 2002). 
1.3.1.1. Translesion Synthesis 
Two different models for the TLS bypass have been proposed; the first, known as 
trans lesion synthesis, consisted of a polymerase-switch (Figure 1.11), where the mono-
ubiquitination of PCNA is the key step and the second, called gap-filling models, involves 
another processivity factor. 
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Translesion synthesis is a highly conserved process, which allows the cells to 
bypass DNA damage using low fidelity DNA polymerases (Figure 1.11). It IS 
characterized by two steps, involving the RAD18 E3 ligase and the RAD6 E2, which 
interact forming a complex and consists in the linkage of a single ubiquitin to K 164 of 
peNA (Hoege et aI. , 2002). In the polymerase switch model, mono-ubiquitination of 
peNA causes a "polymerase switch" in which TLS polymerases like polymerase 11 and K 
and Revl, all of which belong to the Y-family of DNA polymerase, and polymerase~, a B-
family polymerase, replace the more processive B-family polymerases, such as a, 8 and e 
(Kannouche et aI., 2004). This happens because the TLS polymerases interact with peNA 
not only through their PIP box motifs, but also through a Ubiquitin Binding Domain 
(UBD) that gives them much higher affinity for mono-ubiquitinated peNA (Bienko et aI., 
2005; Guo et aI., 2006b; Kannouche et aI., 2001; Ogi et aI., 2005). 
The increase in the level of mono-ubiquitinated peNA is also due to the decreasing 
activity of the Ubiquitin Specific Peptidase (USP1) enzyme, which usually works to 
maintain the ubiquitination of peNA at low level. As a matter of fact, it has been reported 
that upon UV damage, USPI is degraded by a mechanism of autocleavage, at an ubiquitin 
like di-Glycine (GG) motif in its sequence, and thereby allowing higher rates of peNA 
ubiquitination (Huang et aI., 2006). 
Figure 1.11. Polymerases switching. Replication machinery stalls at the site of DNA damage. RAD6/RAD 18 Iigases 
ubiquitinate the PCNA at the K 164. The increasing affinity of the UBZ containing TLS polymerases for the mono-
ubiquitinated PCNA leads to a polymerase switch. TLS replicate past the lesion. Adapted from (Hofmann, 2009). 
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The distinguishing feature of the Y -family of DNA polymerases is the ability to 
replicate through DNA lesions. As a matter of fact they can accommodate bulky adducts, 
like thymine dimers in their active sites. TLS polymerases have a lower processivity than 
the replicative polymerases and also lack the 3'-5' proofreading activity, since the 
appropriate domain is not present (Waters et ai., 2009). 
The TLS polymerases are able to bypass different type of lesion. as shown in Table 
1.2. For example, polymerase TJ is specialized in the replication of the CPOs, which is one 
of the major types of damage caused by UV irradiation (Masutani et aI., 1999). 
Polymerase TJ has an active site, which is large and that allows it to accommodate the entire 
dimer; polymerase TJ replicates the CPDs with the same efficiency as undamaged DNA 
(Washington et aI., 2000; Yoon et aI., 2009). Polymerase TJ appears to be the less 
mutagenic polymerase in bypassing the UV -induced DNA lesion (Johnson et aL 1999). In 
cells from Xeroderma Pigmentousum V -type (XPV) patients, polymerase TJ is not 
expressed, leading to a high UV sensitivity and to a predisposition of the patient to develop 
skin cancer (Masutani et aI., 1999). This cflcct is caused by polymerase TJ being replaced 
by three polymerases, which are less accurate and thus more mutagenic: the model 
describes that polymerase K and t perform the insertion step and collaborate with the 
polymerase ~, which performs the extension step (Ziv et ai., 2009). Polymerase TJ has the 
ability to replicate past other helix-distorting lesions such as 7,8-dihydro-8-oxoguanine and 
06-methylguanine (Haracska et aI., 2000a; Ilaracska et aI., 2000b). 
Polymerase ~ is composed of two domains: the REV3 catalytic subunit and the 
REV7 accessory subunit (Nelson et aL 1996b). Polymerase ~ has been reported to be 
involved in TLS for several adducts, including Benzo(a)pyrene adducts (BP-Gs). 
Cisplatin-GG adducts (cisPt-GGs) as well as across Thymine-Thymine Pyrimidine-
Pyrimidone (6-4) (TT 6-4 PP) (Shachar et aL 2009). Polymerase ~ is inefficient in 
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inserting a nucleotides opposite the lesion, but, as previously mentioned, has a more 
general role in performing the extension step in two-polymerase lesion bypass (Johnson et 
aI., 2000). As an example, it has been reported that BP-Gs are bypassed in reactions that 
involves three different TLS polymerases; in particular, the insertion of the base appears to 
be carried out by polymerase TJ and K, while the new strand of DNA is extended by 
polymerase ~, resulting in a error free or error-prone TLS according to the insertion 
polymerase that is involved (Shachar et aL 2009). 
Polymerase t has a peculiar characteristic; it has different accuracy according to the 
template base. When the template is an adenine, it is changed to a .~yn conformation by the 
two residues of the polymerase finger domain Q59 and K60, resulting in Hoogsteen base 
pairing, in which only the thymine in an anti conformation can be matched. On the other 
hand, when the template is the thymine, it is maintained in the anti conformation and the 
incorporation of an anti guanine, which has a largest stacking surface, is preferred over an 
incoming adenine in syn conformation (Nair et aI., 2004). It also allows the correct 
replication of the 8-oxoguanine adduct that can be correctly matched with an incoming 
cysteine base (Kirouac and Ling, 2011). 
REVl exclusively inserts the de nucleotide opposite the template dG, bulky 
guanines and abasic sites, for this reason, REV 1 is known as a dCMP transferase (Nelson 
et aI., 1996a). REV 1 has a particular mechanism to select the incoming dC nucleotide. The 
R324 residue of REV 1 forms hydrogen bound with the nucleotide avoiding the usual direct 
interaction between the bases pairing (Nair et aI., 2005). REVl possesses a BRCT domain, 
which binds the REV7 subunit of polymerase ~. The BRCT domain, together with an 
Ubiquitin Binding Motif (UBM), mediates the interaction between REVl and PCNA and 
are important for the REVl nuclear foci localization (D'Souza and Walker, 2006; Guo et 
aI., 2006a; Guo et aI., 2006b). In this way, besides its role in transferase activity, REVl 
interacts with the other polymerases, suggesting that it has an important role as TLS 
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polymerase scaffold (Guo et ai., 2003; Ohashi et ai., 2004; Tissier et ai., 2004). 
Once TLS polymerases replicate past the lesion, peNA is de-ubiquitinated by DUB 
enzymes, like USPl, and TLS polymerases are replaced by the more accurate replication 
polymerases (Huang et ai., 2006). 
GENE PROTEIN ROLE (examples) 
Incorporation dC opposite dG 
REVI REVl 
Scaffold for other TLS proteins 
POL H (RAD30AIXPV) POL 11 Replication past CPD 
POLl (RAD30B) POLl Incorporation dT opposite dA 
POLK (DINB!) POL K Replication past BP-G, cisPt, NER 
REV3L POLS Extension step 
Table 1.2. TLS polymerases. V-family polymerases (RIVL POL q. POI. K. POL I.) and the B-family POL; arc 
involved in the translesioll sythesis. 
In the gap-filling model, the TLS is performed to fill the gaps that are left by the 
replication machinery, like the ones that arise from the re-priming of the leading strand or 
the initiation of a new Okazaki fragment (Heller and Marians, 2006). As it has been 
reported in yeast, it is mainly employed during the G2/M phase of the cell cycle. It seems 
that the TLS polymerases that are involved in the polymerase switch TLS, are also 
involved in the gap-filling model, since they are still expressed outside S-phase (Karras 
and lentsch, 2010). 
1.3.1.2. Error Free Pathway 
PCNA can also be poly-ubiquitinated hy the ubiquitin ligase RAD5 in cooperation 
with an E2 enzyme composed of UBC 13 and MMS2 subunits, leading to the formation of 
a K63-linked poly-ubiquitin chain (Brusky et aI., 2000; Hofmann and Pickart, 1999; Ulrich 
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and Jentsch, 2000) (Figure 1.12). Little is known about the resulting downstream process; 
an unknown factor recognizes the poly-ubiquitinated PCNA and initiates the so-called 
error-free pathway. 
Figure 1.12. Error free pathway. PCNA can be poly-ubiqutinated by the complex formed by RAD5/MMS2IUBCI3 
ligases. Poly-ubiqutin chain is then recognized by an unknown factor (orange X), leading to an error free pathway. 
Adapted from (Hofmann, 2009). 
Two possible models for error free-lesion bypass (named also template switching) 
have been proposed, namely recombination and replication fork regression (Figure 1.l3). 
In the fork regression model, the nascent single strand encounters damage in the parental 
strand and there is a regression of the replication fork, which is unwound to generate a 
four-stranded DNA structure called a "chicken foot". In this way the new filament of the 
strand is paired with the nascent filament of the other strand, which is used as a template to 
continue the replication, and the DNA lesion is relocated back into the reformed parental 
duplex. Eventually, fork progression is restored (Chang and Cimprich, 2009; Postow et aI. , 
2001). In the recombination mediated template model there is the formation of aD-loop 
and the nascent strand that encounters the damage invades the other strand (Minca and 
Kowalski, 2010; Chang and Cimprich, 2009). 
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A. FORK REGRESSION B. RECOMBINATION 
Figure 1.13. Two models of template switching error free pathway. Template switching consists of a rearrangement 
of the structure of the replication fork. In the fork regression there is a formation of a "chicken foot" structure (left side), 
whereas in the recombination model there is the formation of a D-Ioop in which one strand invades the other (right side). 
Adapted from (Chang and Cimprich, 2009). 
1.3.1.3. Modification of PCNA by SUMO 
In addition to ubiquitination, PCNA can also be modified by sumoylation (Figure 
1.10). Like ubiquitination, sumoylation takes place in the S-phase of the cell cycle (Hoege 
et aI., 2002) and both modifications of PCNA occur at K164. However it has been 
demonstrated in S. cerevisiae that when K164 is mutated, sumoylation can also occur at 
K127 (Hoege et aI., 2002). 
The consequence of sumoylation of PCNA is still unclear. In yeast, PCNA 
sumoylation may result in the recruitment of the helicase enzyme SRS2 that distrupts the 
RAD51 nucleoprotein filaments preventing unwanted recombination events during S-
phase (Papouli et at, 2005; Pfander et aI., 2005). In particular, SRS2 has been suggested to 
prevents HR by stimulating an ATP-hydrolysis within RAD51 filament, thus driving 
RAD51 to be liberated from the DNA (Antony et aI., 2009). It has been demonstred that 
the binding of SUMO to PCNA can prevent the interaction between PCNA interacting 
proteins and PCNA. As a matter of fact, sumoylation of PCNA represses the Establishment 
of COhesion protein 1 (ECO 1 )-dependent cohesion in yeast (Moldovan et at , 2006). 
Recently, sumoylation of PCNA has been characterized in humans where it has 
been reported to restrict DSB formation and unnecessary recombination when the 
replication fork stalls (Gali et at, 2012). The human PCNA Associated Recombination 
Inhibitor (PARI) shows a high affinity for the SUMO/PCNA and has been demonstrated to 
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work as an SRS2 analog by limiting the formation of RAD51-DNA nucleofilaments 
(Moldovan et aI., 2012). 
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SECTION B: Ubiquitination 
Ubiquitin is a highly conserved protein found from yeast to mammals. 
Ubiquitination is a post-translational modification process that results in the covalent bond 
forming between ubiquitin and another protein; specifically it involves the carboxylic acid 
of the terminal Glycine of the ubiquitin and the amine of a Lysine residue on the target 
protein. It mainly serves as a signal for proteolytic degradation and as a scaffolding 
molecule in the formation of protein-protein interaction. 
1.1. Ubiquitin 
Ubiquitin is a 76 amino-acid polypeptide that possesses 7 Lysine residues and has a 
molecular mass of 8.5 kDa. It is present in all eukaryotic cells and is found throughout the 
cell. Ubiquitin is encoded by four different genes, namely UBA52, UBA80, UBB, UBC 
and all of them express ubiquitin as a large precursor (Ozkaynak, Finley et al. 1984; Lund 
et aI., 1985). In particular the UBA gene codes for a single copy of ubiquitin fused to a 
ribosomal proteins L40 and S27 and the lJBB and UBC genes code for a polyubiquitin 
head to tail fused precursor proteins (Wiborg et aL 1985). In order to have a mature free 
ubiquitin, the fusion protein must be processed. De-UBiquitinating (DUBs) enzymes 
cleave the peptide bonds between the ubiquitin molecules obtaining a 76 amino acids 
containing protein (Finley et aI., 1989; Lund et aI., 1985; Ozkaynak et aI., 1987; Ozkaynak 
et aI., 1984). 
1.1.1. Ubiquitination Enzymes 
The ubiquitination pathway initiates with the activation of ubiquin (Ub) by the Ub-
activating enzyme E I in the presence of ATP (Figure I. I 4). The activated ubiquitin is then 
transferred to a Ub-eonjugating enzyme E2 and eventually, is transferred to the target 
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substrate protein, in a process that typically involves an E3 Ub-ligase (Hershko et ai., 
1983). 
When the ubiquitination cascade begins, an ubiquitin adenylate intermediate, in 
which ubiquitin and adenosine monophosphate (AMP) are conjugated by a high-energy 
thioester bond, is formed. This intermediate is then coupled to the E 1 through a non-
covalent bond. At this point the activated ubiquitin protein is transferred to a Cysteine 
residue on Eland AMP is released. The E l-ubiquitin complex transfers the ubiquitin to an 
E2 enzyme through a transthioesteritication reaction and the E 1 ubiquitin-activating 
enzyme is then released. 
Two ubiquitin specific E 1 enzymes have been described in human, namely UBE 1 
and UBA6 (Jin et ai., 2007). There are approximately 40 E2 enzymes in humans, which are 
characterized by the presence of an UBiquitin Conjugating (UBC) domain, of around 150 
amino acids, which contains the catalytic Cysteine residue and interacts with the E 1 (van 
Wijk and Timmers, 2010). 
The E2-ubiquitin complex is then recognized by an ubiquitin ligase (E3), of which 
there are several hundred. They are divided in two major types: the catalytic Homologous 
to the E6-AP Carboxyl Terminus (HECT) domain E3s and the adaptor Really Interesting 
New Gene (RING) finger based E3s (Figure 1.14). 
The HECT ligase is composed by two parts, in which the N-terminus interacts with 
the substrate and C-terminus contains the BECT domain. The HECT domain in turn has a 
C-terminal lobe that binds the ubiquitin and an N-terminal lobe, which is important for its 
interaction with the E2 conjugating enzyme (Huang et aL 1999). During conjugation, the 
ubiquitin molecule is first transferred to a Cysteine residue in the l-IECr sequence and then 
transferred to the Lysine of the substrate. The first member of the family to be discovered 
is the E6-Associated Protein (E6AP), which cooperates with the oncoprotein E6 in 
stimulating p53 ubiquitination and degradation (Talis et aI., 1998). 
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The second family includes the RING E3 finger that has a zinc atom coordinated by 
Cysteine and Histidine residues (Lorick et aI., \999). RINGs have the ability to catalyse 
the direct transfer of ubiquitin from E2 ligases to the Lysine of the target proteins. In 
general, RING E3s can act as a single or a multiple component. The RING E3 MDM2, 
which is an example of a single component E3, has an important role in maintaining the 
low basal level of the tumor suppressor p53. As a matter of fact, MDM2 binds p53 and 
promotes its ubiquitination, leading to its proteasomal degradation (Haupt et aL 1997; 
Honda et ai., 1997). When DNA damage occurs, MDM2 and p53 are phosphorylated and 
thus no longer able to interact. As a consequence, the level of p53 increased (Maya et aL 
2001; Unger et ai., 1999). 
The Skp 1 ICullinlF box protein (SCF) and Anaphase Promoting Complex (APC) are 
two members of the E3 family that act as muiticomponent complexes and are involved in 
the regulation of the correct progression of the cell cycle. APC consists of more then 
thirteen subunits, whereas SCF consists of S-phase Kinase associated Protein 1 (SKP 1), 
Cullinl, F-Box and a RING finger component Ring BoX proteinl (RBXl). Cullins are 
subjected to a process known as neddylation. where the ubiquitin-like protein NEDD8 is 
coupled to a conserved Lysine residue at its C-terminus (Osaka et ai., 1998); the 
attachment of NED08 leads to a conformational change of SFC, in which RBX acquires 
enhanced catalytic activity (Kawakami et ai., 200 \). Moreover, cullin neddylation prevents 
the interaction with its inhibitor, Cullin-Associated and Neddylation-Dissociated 1 
(CANOl )(Liu et ai., 2002). 
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Figure 1.14. Ubiquitination pathway. Ubiquitination is a three-step enzymatic process. The first step consists of the 
A TP-dependent activation of ubiquitin, which is transferred to the Ub-activating (E I) enzyme. In this step there is the 
formation of a thioester bond between the C-terminal of Ub and the cysteine of the active site of E I. In the second step, 
ubiquitin is transferred from the E I to the cyste ine of E2 with a formation of a new thioester bond. In the third step, E2-
ubiquitin complex is recognized by an E3 ligase. HECT type ligases bind the active ubiquitin and transfer it to a Lysine 
residue of the substrate protein. The RING finger-type ligases transfer the active ubiquitin directly from the E2 enzyme to 
the substrate protein. Adapted from (Kawabe and Brose, 20 11). 
1.1.2. De-Ubiquitination 
De-ubiquitinating enzymes are a group of proteases that cleave the isopeptide bond 
on the carboxy-terminal side of G76 of ubiquitin thus releasing the ubiquitin linked to the 
protein. In this manner ubiquitination can be reversed without degrading the substrate 
protein. In humans there are around 100 DUBs that can be divided in five families namely 
USP, UCH, OTU/Cezanne, MJD, which are Cysteine proteases and JAMM, a zmc-
dependent metalloproteases (Amerik and Hochstrasser, 2004), listed in Table 1.3. 
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DE-UBIQUITINATING 
NAME TYPE 
ENZYMES 
Ubiquitin-Specific Processing USPs Cysteine proteases 
Ubiquitin Carboxyl-terminal 
ueHs Cysteine proteases 
Hydrolase 
Ovarian TUmour OTUs Cysteine proteases 
Machado-Josephin Domain MJDs Cysteine proteases 
Jab 1 IMPN/Mov34 Metalloenzyme .IAMMs Zinc metalloproteases 
Table 1.3. De-ubiquitylating enzymes. In humans there are sound 100 DUBs that can be divided in five families: USPs. 
lJCHs. OTlJs. MJDs and .IA.MMs. 
As mentioned before, ubiquitin is translated as a long polymer, which possesses 
multiple ubiquitin subunits (Figure 1.15). DUBs enzymes, such as Ubiquitin Carboxy-
terminal Hydrolase L I (UCH-L I), process ubiquitin precursor in order to obtain ubiquitin 
monomers (Larsen et aI., 1998). De-ubiquitination mainly serves to regulate the stability of 
the proteins that are targeted to proteasomal degradation and to maintain the homeostatic 
level of free ubiquitin in the cell. As a matter of fact, de-ubiquitination of p53 by the 
Herpesvirus-Associated Ubiquitin Specific Protease (HA-USP) protects p53 from 
proteasomal degradation (Li et aI., 2002). DUBs can also act in exchanging two different 
types of poly-ubiquitin chains. One example is the OTU-type DUB A20, which is an 
inhibitor of NF-KB signalling. In fact A20 removes K63 ubiquitin chains from the 
Receptor Interacting Protein (RIP), which is a mediator of the proximal Tumor Necrosis 
Factor Receptor (TNFRl) signalling complex and binds K48 chains to RIP. Thus A20 acts 
as a negative regulator of NF-KB signalling targeting RIP for proteasomal degradation 
(Wertz et aI., 2004). 
At the level of the proteasome, poly-ubiquitin chains are released from the ubiquitin 
conjugated protein, thereby recycling ubiquitin (Verma et aI., 2002; Yao and Cohen, 
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2002). This prevents both the degradation of ubiquitin and its interference with the protein 
entering into the proteasome. In Figure 1.15 are reported the general roles of DUBs. 
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Figure 1.15. General roles of DUBs. A) The precursor o f ubiquitin is translated as a fusion protein of multiple copies of 
ubiquitin. DUB must be cleaved at the K76 in order to obtain the mature form of the protein. B) DUBs avoids the 
degradation of the ubiquitinated protein. C) At the leve l of proteasome, DUBs remove poly-ubiquitin chains from the 
SUbstrate protecting the poly-ubiquitin chain from degradation. D) DUBs remove poly-ubiquitin chains promoting the 
SWitching with other type of poly-ubiquitin chains. E) DUBs cleave the isopeptidic bond between poly-ubiquitin chains 
thus mantaining the homeostatic level of free ubiquitin pool. Adapted from (Komander et aI. , 2009). 
1.1.3. Types of Ubiquitination 
Ubiquitination acts as an important signalling molecule and the information that it 
transmits depends on the type and the nature of the ubiquitin chain (Table 1.4). As a matter 
of fact, proteins can be modified by mono-ubiquitination, which consists in the conjugation 
of a single ubiquitin molecule to one of the Lysines of the protein target and/or be poly-
ubiquitinated, when further ubiquitin are attacJ1ed to the ubiquitin monomer. 
Mono-ubiquitination was -first found in histones H2A (Goldknopf et aI. , 1975). It 
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was described as a mechanism for the regulation of the chromatin structure and gene 
expression (Zhang, 2003). In both yeast and mammals. it has also been found to regulate 
membrane receptors, which are down-regulated by internalization into the endocytic 
pathway after being mono-ubiquitinated (Terrell et ai., 1998). Multiple mono-
ubiquitination, where a single ubiquitin is hound at ditTerent sites, can also regulate the 
endocytosis (Haglund et ai., 2003). In addition, Uhiquitin Binding Domains (UBDs) can 
mediate mono and poly-ubiquitination of the proteins that contain them in a process known 
as coupled ubiquitination (Bish et aL 2008; Hoeller et ai., 2006). Coupled mono-
ubiquitination can result in auto-inhibition through an intra-molecular interaction between 
the conjugated ubiquitin molecule and the ubiquitin-binding domain. as reported for the 
Suppressors ofT-cell receptor Signaling (STSs) proteins and more recently for polymerase 
11 (Bienko et ai., 2010; Hoeller et aL 20(6). 
The linkage of many ubiquitin molecules to the same target protein is defined as 
poly-ubiquitination. Poly-ubiquitin chains can he formed through one of the seven Lysines 
present in the ubiquitin: K6, K 11, K27. K29. K3J. K48 and K63. These chains can be of 
different lengths and shapes and have been associated to different pathways (Table 1.4). 
The canonical signal for proteasomal degradation is the K48 poly-ubiquitin chain 
(Chau et ai., 1989) although K29 linked chains have also been found on target proteins 
toward this machinery (Johnson et ai., 1(95). It has been found that Kll-linked chains. an 
abundant type of poly-ubiquitin chains in the cells, may act as a signal for proteasome 
degradation in the Endoplasmic Reticulum Associated protein Degradation (ERAD) 
pathway (Xu et aL 2009). In yeast it appears that the ultimate fate of all the chains. except 
K63. is proteasomal degradation (Xu et aL 20(9). 
Nevertheless. the other poly-ubiquitin chains. except K48, are also involved in non-
proteolytic pathways and they play a role in processes including DNA repair and 
inflammation. K63 has been reported to be important in the DNA damage response. In 
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S.cerevisiae, mutation of the K63 renders the cell highly sensitive to UV irradiation 
(Spence et aL 1995). K63 chains also playa role in DNA damage tolerance, as described 
in the paragraph 1.3.1.2. (Hoege et ai., 2002). K63 chains also have an important role in 
NF-KB activation by Tumor Necrosis Factor a (TNFa.) In this case. UBC13/MMS2 is 
paired with specific E3s to target different intermediates of these pathways. The TNF 
Receptor Associated Factor 2 (TRAF2) E3. for examples. mediates the poly-ubiquitination 
of the Receptor Interacting Protein (RIP) during TNFa signalling and these chains are then 
recognized by the ubiquitin binding protein NF -kappa-B Essential MOdulator (NEMO). 
which induces the activation of the IKB Kinase (IKK) (Ea et aL 2006; Li et aL 2006; 
Wertz et ai., 2004; Wu et aL 2006). 
Besides these pathways, the roles of other types of poly-ubi quit in chains have been 
reported and poly-ubiquitin chains with mixed linkage have also been described. For 
example K29/K33 linked mixed chains have been described in the regulation of AMP-
activated protein Kinase (AMPK)-related kinases (AI-Hakim et aL 2008). Linear poly-
ubiquitin chains are a particular type of poly-ubiquitin chains, which are assembled by the 
E3 ligase known as the Linear UBiquitin chain Assembly Complex (LUBAC): these types 
of chains are generated through the linkage between the N-terminal Methionine of one 
ubiquitin and the C-terminal Glycine of another ubiquitin molecule and have been shown 
to be involved in the NF-KB activation (Kirisako et aL 2006; Tokunaga et aL 2009). 
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CHAIN ROLE(S) 
K6 DNA repair 
Kll ERAD 
K27 ') 
K29 Degradation 
K33 ? 
K48 Degradation 
K63 DNA repair, damage tolerance, inflammation 
Table 1.4. Types of poly-ubiquitin chains. lJbiquitin monomers can be asscmbled to form poly-ubiquitin chains. which 
are ronned through the seven internal Lysine residues. Different poly-ubiquitin chains are associated to different 
pathways. Adapted from (Wong and Cuervo. 2010). 
1.1.4. Proteasomal Degradation 
The main function of the proteasome is to degrade ubiquitin targeted proteins by 
proteolysis (Figure 1.16). It is present inside all eukaryotes. archaea and in some bacteria 
and is located in both the nucleus and cytoplasm (Peters et aL 1994). 
The proteasome is a cylindrical complex, which consists of one 20S core particle. 
capped at one or both ends by a 19S complex. known as the 19S regulator complex (Peters 
et ai., 1994) (Figure 1.16). The 20S subunit is composed of four rings around a central 
pore. Each ring contains seven subunits and the two inner rings contain 7 ~-type 
proteolytical subunits, while the external ones are formed by 7 a-type subunits. acting as a 
gate through which proteins can enter (Groll et aL 1997). The 19S subunit is involved in 
the recognition and unfolding of poly-ubiquitinated substrates and in opening the 20S gate 
(Smith et ai., 2007). The 19S particle is formed by two subunits: the base and the lid 
(Glickman et ai., 1998). The base contains ten subunits, of which six are ATPase subunits 
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(RPTI-RPT6) and four are non-ATPases (RPNL RPN2, RPNlO, RPN13). The lid has nine 
subunits among which there is the de-ubiquitylating enzyme RPNll (Glickman et al., 
1998; Verma et al., 2002). Ubiquitinated proteins can be directly recognized by 
RPN 10/S5a and RPN 13/ Adrm I receptors 0 r the base 19S of the proteasome or can be 
escorted to the proteasome by the shuttle I~lctors, like the Radiation Sensitive 23 (RAD23). 
which bind the substrate through their UBiquitin-Associated (UBA) domain and interact 
with proteasome through its UBiquitin-Like (UBL) domain (Deveraux et al.. 1994; 
Husnjak, Elsasser et al. 2008; Chen and Madura, 2002). These proteins recognize the 
ubiquitinated substrates and drive them into the proteasome. Proteins first pass through the 
translocation channel of the 19S subunit. Proteins with folds that are too large to enter 
channel are unfolded by ATPase activity of the 19S subunit (Wenzel and Baumeister. 
1995). The ubiquitin linked to the protein is removed by the proteasome associated DUB 
subunits. In this way, ubiquitin can be recycled and it does not interfere with the entrance 
of the protein in the proteasome (Verma et al.. 20(2). Together the DUBs and unfolding 
activities allow the protein to enter the protcasome, where the mechanism of proteolysis is 
carried out by the B subunits of the 20S core particle in a trypsin-like and chymotrypsin-
like fashion (Heinemeyer et al., 1997). 
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Substrate ubiquitination 
19S 
Ire: ml lor} 
20S Proteasomal degradation 
(cor) 
19S 
(rc ~uJalorl 
LBAdmlin 
LBL damin Degraded protein 
Figure 1.16. Proteasomal degradation. Proteasome is composed by 20S core and 19S regulator particles. 20S particle is 
composed by four rings : two a gates and two P proteolytic subunits. Ubiquitinated protein are recognized directly by the 
receptors of the base 19S or escorted by shuttle factors which bind the substrate through the UBA domain and interact 
with proteasome by UBL domain. 
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SECTION C: Ubiquitin Binding Domain Containing 
Proteins 
Many proteins possess one or more Ubiquitin Binding Domains/Motifs 
(UBDs/UBMs), which interact with mono- and/or poly-ubiquitin chains (Table 1.5). The 
recruitment of UBD containing proteins to other ubiquitinated proteins translates the 
ubiquitin signal into the appropriate response. 
1.1. Ubiquitin Binding Domains 
In many cases, a set of domains known as Ubiquitin Binding Domains (UBDs) 
recognizes ubiquitin and ubiquitinated proteins. Based on their structure, UBDs have been 
classified into twenty different groups, in which the largest family comprises domains that 
interact with ubiquitin through a a-helix, such as the Ubiquitin Associate (UBA) and the 
Ubiquitin Interacting Motif domain (UIM) (Table 1.5). The second largest group 
comprises UBDs that have a zinc finger in their sequence, such as the Npl4 Zinc Finger 
domain (NZF) and the Ubiquitin Binding Zinc finger domain (UBZ). UBDs are listed in 
Table 1.5 (panel A). So far, five UBDs are known to be involved in DNA damage repair: 
the UBA (Hofmann and Bucher, 1996), UIM (Hofmann and Falquet, 2001), the Ubiquitin 
E2 Variant (UEV) (Koonin and Abagyan, 1997; Ponting et aI., 1997), the Ubiquitin 
Binding Motif (UBM) and UBZ domains (Bienko et aI., 2005). For example, the Receptor 
Associated Protein 80 (RAP80), which is involved in the recruitment of BRCA 1 to sites of 
DNA damage, contains two IUMs (Yan et aL 2(02). RAP80 UIMs preferentially binds K6 
and K63 poly-ubiquitin chains, which are synthetized at the damage sites (Sobhian et aL 
2(07). 
The UBZ domain was first described in the Y -family DNA polymerases TJ and K 
(Bienko et aI., 2005) and have been reported in other proteins such as WHIP (Bish and 
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Myers, 2007) and RAD18 (Notenboom et a!., 2007). Between all the UBZ domains that 
are listed in Table 1.5, (panel B), UBZ4, which is a C2HC zinc finger domain, has been 
found in Ubzl (also called Spartan or DVel) protein (Centore et aI., 2012), and this 
protein is the major subject of my thesis work. 
A 
Protein 
Symbol Name 
examples 
UBA UBiquitin Associated RAD23 
RAP80, Ataxin 
UIM UBiquitin Interacting Motif 
3 
UBZ Ubiquitin Binding Zinc finger RAD18, WHIP 
UBM Ubiquitin Binding Motif REVl 
GLUE GRAM Like Ubiquitin binding in EAP45 EAP45 
NZF Npl4 Zinc Finger Npl4 
DUIM Double sided Ubiquitin Interacting Motif HRS 
MIU Motif Interacting with Ubiquitin Rebex5 
GAT GGA and TOM GGA, TOM 
PFU PLAA Family Ubiquitin binding domain PLAA 
VHS Vps27/11rs/STAM STAMl 
SH3 Src Homology 3 Cin85 
Coupling of Ubi quit in conjugation to 
CUE SMRCD 
Endoplasmatic reticulum degradation 
UEV Ubiquitin E2 Variant MMS2 
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B 
Symbol Protein examples Structure 
UBZ1 TAXIBPI C2H2 
UBZ2 FLJ44922 C2HC 
UBZ3 Polymerase 11 C2H2 
Polymerase K, WHIP, 
UBZ4 C2HC 
RadlS, Ubzl 
Table 1.5. Ubiquitin binding domains. The table in panel!\. shows many of UBDs and some examples of proteins 
where they have been found. In table in panel B arc listed the lJBZ domain types. their structure and examples of protein 
where they have been found. 
1.2. Ubiquitin Binding Proteins 
Proteins that contain the Ubiquitin Binding Zinc finger domain 3 and 4 
(UBZ3/UBZ4) have been found to be involved in DNA replication and repair pathways. 
Six proteins containing UBZ 3 and 4 domains have been reported: RADI8 (Notenboom et 
ai., 2007), WRNPIIWHIP (Bish and Myers, 2007), polymerase 11 and K (Bienko et ai., 
2005), the Sensitive to Nitrogen Mustard I A (SNMIA) (Yang et aI., 2010) and 
C I ORF 124 (Spartan/DYCIIUbzl) (Centore ct aI., 2012) (Figure 1.17). 
All of these proteins are involved in DNA damage repair; RAD 18, polymerase 11 
and K participate in DNA damage tolerance and SNM1A in the repair of DNA interstrand 
crosslinks (Hoege et aI., 2002; McDonald et al., 1997; Ulrich and Jentsch, 2000; Wagner et 
ai., 1999; Yang et aI., 20 10). The role of WIll P remains unclear and most of the studies on 
molecular function have been done on the yeast homologue MGS 1. It has been reported 
that MGS I is required for genome stability of budding yeast and that it blocks the activity 
of the RAD6 pathway in the absence of an exogenous DNA damage, via interactions with 
rCNA (Hishida et aI., 2001; Hishida et aI., 2002; I lishida et aI., 2006). 
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UBZ3/4 domains are important in directing the protein to the site of DNA damage. 
A single point mutation in the UBZ domain of the two Y-family polymerases impedes 
their binding to mono-ubiquitinated PCNA; as a consequence, after DNA damage, mutant 
pol'll and K are not localized to nuclei foci and cannot participate in TLS (Bienko et aI., 
2005). Similarly, the UBZ domain ofRAD18 is also required for the protein to migrate to 
the sites of DNA damage (Nakajima et aI., 2006). 
More recently it has been demonstrated that the SNMIA protein, which is required 
for cellular processing of inter-strand DNA crosslinks, also possesses a conserved UBZ 
domain, which appears to be important in binding mono-ubiquitinated PCNA. Also in this 
case, DNA damage drives SNMIA to nuclear foci in a UBZ-dependent manner (Yang et 
aI., 2010). 
Ubzl 
Rad18 
Whip 
POlK 
SnmlA 
Figure I.l7. UBZ containing proteins. UBZ domains are reported as UBZ3 (C2H2) or UBZ4 (C2HC) zinc finger. 
Ubzl, RADS, WHIP, POLK and SNMIA contain a UBZ4 domain. UBZ3 has been found only in POLl]. The main 
difference between the two domains is the forth ligand, which is a Histidine in UBZ3 and a Cysteine in UBZ4. All of 
these proteins are involved in DNA damage repair pathways. 
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1.2.1. Clorf124 (Spartan/DVCt/Ubzt) 
K6 poly-ubiquitin chains have been found to be involved in DNA damage-related 
signalling pathways (Wu-Baer et aI., 2003). In order to identify proteins that bind K6 poly-
ubiquitin chains, my group performed a proteomic screen. The top candidate for the 
interaction with the K6 poly-ubiquitin chain was WHIP and the ubiquitin interacting 
sequence was found to be Rad I8-like zinc finger, which was a bonafide Ubiquitin Binding 
Zinc finger domain (UBZ) (Bish and Myers, 2007). Using a database search for UBZ 
domains, we found six human proteins with putative UBZ domains: RAD 18, WHIP, 
polymerase 11 and K, SNMIA, and the uncharacterized protein CIORFI24, renamed 
UbzllSPARTAN/DVCI. 
Ubz1 is a 489 aa protein of 55 kDa, which is encoded by the C 1 ORF 124 gene. At 
the N-terminus, it contains an SprT domain of 167 aa, which has a putative zinc 
metalloproteasic activity. At the C-terminus, it presents a PIP motit~ which is important for 
its interaction with peNA, and a UBiquitin Zinc finger (UBZ4) domain (Centore, Yazinski 
et aI. 2012). In vitro pull-down experiments confirmed that the UBZ domain of Ubzl 
binds ubiquitin. In particular, the UBZ domain can bind K48 and K63 poly-ubiquitin 
chains (Centore et aI., 2012). Different mutations in the UBZ domain sequence are able to 
completely abolish the capacity of Ubz 1 to bind ubiquitin; these are the single point 
mutation D473A (Machida et aI., 2012) and the double mutations C456A/C459A or 
C456G/C459G (Davis et aI., 2012; Mosbech et aI., 2012; Centore et aI., 2012). 
As has been previously described, ubiquitination of PCNA appears to act as a 
switch that controls the decision between S phase specific DNA repair pathways. The UBZ 
domain has a role in directing proteins to the site of DNA damage via its ability to bind to 
ubiquitinated PCNA. This role has been proposed because the UBZ containing proteins 
polymerase 11 and K and RAD 18 are all found in DNA damage induced nuclear foci and 
their localization requires a functional UBD (Bienko et aI., 2005; Crosetto et aL 2008; 
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Nakajima et aI., 2006). Many UBZ-containing proteins do not interact with peNA 
exclusively through their UBZ domains, because they also possess a PIP motif (Warbrick 
et ai., 1995); the PIP box motifs are involved in the interaction between peNA and three 
UBZ containing proteins: polymerase 11 (ilaracska et ai., 200 I) and polymerase K 
(Haracska et aI., 2002) and SNM 1 A (Yang et ai., 20 10). Other proteins interact with 
peNA even if they do not have a PIP box motif; for example, RAD 18, which is involved 
in peNA ubiquitination, has been found to have peNA binding motif in its N-terminal 
region, which does not match with the PIP box motif (Notenboom et ai., 2007). Thus, the 
UBZ domain and the PIP box motif work together in mediating the physical interaction 
between these UBZ containing proteins and peNA. 
The PIP box of Ubzl is an 8 amino acids sequence, which has an important role in 
the interaction with the peNA. In vitro pull-down experiments showed that deleting the 
entire motif (Ghosal et ai., 2012), or mutations of residues Q325A, L328A, Y331A, and 
F332A (Davis et ai., 2012) or even of just Y331 A and F332A (Machida et ai., 2012; 
Mosbech et ai., 2012), completely abolish the capacity of Ubzl to bind peNA. 
The Sprt domain carries a conserved metalloprotease HExH motiC which is found 
in many zinc metalloproteases (Rawlings and Barrett 1995; Jongeneel et aI., 1989). In the 
SprT domains, the zinc ion is coordinated by two Histidine residues. A Glutamic acid and 
a molecule of water work together in the cleavage of the isopeptidic bond (Kim et ai., 
2013; Rawlings and Barrett, 1995). However, no eukaryotic proteins with this domain have 
been functionally characterized. 
The goal of my thesis has been to better characterize Ubzl. In particular, I 
investigated the interaction between Ubzl and peNA using SprT and UBZ domain mutant 
constructs. In addition, Ubzl appeared to be subjected to an SprT-dependent autocleavage 
and my results suggested that the SprT domain has a metalloprotease function. 
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2. METHODS 
2.1. Solutions 
• PBS buffer: 137 mM NaCl, 2.7 mM KCI, 10 mM NaH2P04, 2mM K2HP04, pH 7.4 
• TBS buffer: 50 mM Tris base, 150 mM NaCI, pH 7.4 
• TTBS buffer: I x TBS, 0.1 % Tween-20 
• BBS 2x: 50 mM Bes, 280 mM NaCl, 1.5 mM Na2HP04, pH 7 
• LB medium (Luria-Bertani medium): 109 tryptone, 5 g yeast extract, 109 NaCI in 
1 L, pH 7.5-8) 
• TB (Terrific-Broth): 12 g tryptone, 24 g yeast extract, 9.4 g K2HP04, 2.2 g 
KH2P04, 4 mL glycerol in 1 L 
• LYSIS BUFFER: 50 mM Hepes pH 7.4. 150 mM NaCl, 1 mM EDTA, 0,1% NP40 
• UREA BUFFER: 8 M urea, 10 mM Tris-HCI, 115 mM NaH2P04, 300 mM NaCl, 
and 0.1 % NP40, pH adjusted to 8.0 with NaOH 
• BLUE COMASSIE: 10% (NH4hSnl • 0.03% Comassie BB 0250, 2.5% H3P04, 
20% Ethanol 
• 0.2 M IMIDAZOLE 
• 0.1% SDS 
• 0.2 M ZINC SULFATE 
• DI-AP (DIAMMONIUM PHOSPHATE) pH 8 
• 50% MEOH 20 mM di-AP 
• 200 mM IODOACETAMIDE 
• 5% FORMIC ACID 
• 100% ACN (Acetonitrole) 
• 0.2% TF A (Tritluoroacetic acid) 
• 50% ACN/50% TF A 0.2% 
• H201 10% glycerol 
• 2.5M CaCh 
• 2x LAEMMLI BUFFER: 4% SDS, 20% glycerol. 0.125 M Tris HCl, 0.004% 
Bromophenol blue, 10% beta-mercaptocthanol, pI I 6.8 
• NP40 BUFFER: 1 X PBS, 140 mM NaCI. 1% NP40 
• TCEP: tris(2-carboxyethyl)phosphine 
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2.2. DNA and Cloning 
2.2.1. Plasm ids Construction 
The pHA-MA T derives from the pCGN vector and its construction has already 
been described (Bish et aI., 2008). Full length Ubzl was cloned from a sequence verified 
cDNA MHSIOIO-7508511 (Open Biosystems) by PCR into pHA-MAT. The D473A, 
HIll LIE 112A, E 112A Ubz 1 mutants were generated using the site-directed mutagenesis. 
The pCGT7 vector derived from the pCG vector in which the T7 tag (MASMTGGQQMG) 
was inserted. The full length Ubzl was inserted by ligation into the pCGT7. The PCNA 
Ub-PCNA and 4Ub-PCNA constructs, synthetized by Genescript, were digested with XbaI 
and BamHI and ligated into pHA-MAT and peGT7 using standard techniques. 
2.2.2. Site Directed Mutagenesis 
PCR- In order to build pHA-MAT-Ubzl D473A, E112A, HlliLlEl12A mutants, pHA-
MAT-Ubzl WT was used as a template. The mix was composed by: 20 ng DNA, 1 x 
ThermoPol buffer (NEB), MgS04 4 mM, dNTPs mix (200 llM), 250 nM oligonucleotides 
primers. 
Primers: 
• pHA-MAT-Ubzl (El12A): 
FORWARD 5'-AGACCCTCCTGCATGCAATGATACATGCCTA 
REVERSE 3' -T AGGCA TGT A TCCATTGCA TGCAGGAGGGTCT 
• pHA-MAT-Ubzl (Hl11LlEl12A): 
FORWARD 5'-AGACCCTCCTG!=]TGCAATGATACATGCCTA 
REVERSE 3'-TAGGCATGTATCCATTGCAACiCAGGAGGGTCT 
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Cycling parameters for the quickchange site directed mutagenesis: 
SEGMENT CYCLES TEMPERATURE TIME 
1 1 95°C 30 sec 
2 18 95°C 30 sec 
55°C 1 min 
68°C 1 minlkb (circa 6,5 
min) 
Table 2.1. peR cycles of site directed mutagenesis. 
DNA DIGESTION- At the end of the reaction, samples were kept in ice for 2 minutes to 
be cooled and the template plasmids were digested via the addition of NEB ButTer 4 (to 
1 x) and 1 f.lL of Dpnl. The reaction was incubated for 1 h at 37°C. 
TRANSFORMA TION- 2 f.lL of the digestions were electroporated in GC 10TM 
electrocompetent cells at 1500 V and resuspended in 960 f.lL of LB medium. The 
transformation was incubated Ih at 37°C and 40 f.lL of the reactions were plated on the 
agar plate, supplemented with the antibiotic. 
ELECTROCOMPETENT CELLS- 40 mL of GCl01M cells were grown overnight at 
37°C. The day after they were diluted 1110 into 400 mL LB and growth until 00600 ~ 0.75 
and chilled on ice. Cells were pelleted at 4000x g at 4°C for 15 minutes and then 
resuspended in 400 mL sterile ice-cold water. Cells were pelleted again at 4000x g for 15 
minutes and resuspended in 200 mL sterile cold water. This step was repeted four times 
and at the end cells were resuspended in 800 ~Ll. sterile cold water/ 10% glycerol and 
aliquoted before storing at -80°e. 
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DNA SEQUENCING- DNA was prepeared using the Qiagen mini-prep kit and the entire 
cDNA was sequenced by "BMR Genomics", using 300 ng of DNA and 6.4 pmol of 
primer. The presence of the mutations were confirmed using the "4Pics" program. 
2.3. Cells handling 
2.3.1. Cell Culture 
HEK 293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Sigma 
Aldrich) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 50 U/mL 
penicillin, 100 Ilg/mL streptomycin B, 25 ng/mL amphotericin B. 
2.3.2. Transfection 
Plasmids were purified from GCI 0 E.co/i using GenEluted 1M HP Endotoxin-Free Plasmid 
Maxiprep Kit. Plasm ids have been transfected into HEK293T cells using the calcium 
phosphate transfection method. Cells were plated the day before transfection in order to 
have a confluence of 40% the day of the transfection. The mix used for the transfection of 
a 10 cm dish was composed by: 60 ilL CaCh 2.5 M, 10 Ilg DNA and t-hO to final volume 
of 500 ilL and 500 ilL of 2x BBS was added drop wise while agitating the tube. The 
resulting mixture was then added over the cells and incubated for 24 hours. The 
transfection mix was removed and the cells washed I x with PBS and returned to their 
growth media. 
2.4. Protein Purification 
2.4.1. Lysates Collection 
Two days after transfection, cells were washed twice with ice cold PBS. Lysates were 
resuspended in the lysis buffer, sonicated in 0.5 seconds bursts for I minute at an 
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amplitude of 60% usmg a Hielscher sonicator fitted with a voltmeter adapter, and 
centrifuged 10 minutes at 13000 rpm. Bradford assay method (Sigma Aldrich) was used in 
order to measure the protein concentration in the Iysates collected. The manufacturer's 
instructions were followed. Laemmli ButTer 2x (Sigma) was added to the Iysates and 
samples were boiled for 5 minutes. 
2.4.2. Immunoprecipitation 
Agarose beads (ezviewTM Red Anti-HA Affinity gel, Sigma-Aldrich or T7-Tag antibody 
agarose beads, Novagen), were equilibrated in the lysis buffer. Lysates were transferred to 
the beads and kept rotating for I h at 4°C. I mmune-complexes were washed three times 
with lysis buffer, transferred in new tubes then washed twice with the PBS supplemented 
with 0.1 % NP40. 2x Laemli Buffer (Sigma) was added and samples were boiled. 
2.4.3. Peptide Elution 
After the immunoprecipitation with the beads, protein complexes were eluted 3x for 20 
minutes with a HA peptide in lysis buffer (200llg/mL final concentration). Samples were 
transferred in the speedvac. Laemmli Buffer 2x (Sigma) was added and samples were 
boiled. 
2.4.4. Denaturing Tandem Affinity Purification 
After the I-hour IP, beads were washed three times with the lysis buffer. For urea elution, 
2 x 200 ilL of urea buffer was added directly to the antibody-conjugated beads, and the 
supernatant was removed following three minutes incubation at room temperature. The 
supernatant was then incubated with the Ni-NTA beads (Sigma Aldrich) (pre-equilibrated 
with urea buffer) at room temperature for I hour. The beads were washed 4 times with the 
urea buffer and three times with the lysis buffer. Lamemli Butfer 2x (Sigma) supplemented 
with 1 mM TCEP and 33 mM EDTA was added and the samples were boiled for 8 minutes. 
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2.5. Protein Visualization 
2.5.1. Protein Staining 
COLLOIDAL BLUE COMASSIE STAINING- Gels were stained with the colloidal 
blue Comassie for at least 1 hour and then rinsed with water. 
ZINC ST AINING- Zinc stain deposits a zinc metal precipitate in the gel. The SDS 
coating on the proteins prevents the stains from binding to the proteins, while the gel turns 
white. SDS-PAGE gels were put on an orbital mixing platform in the Imidazole solution 
for 10 minutes and then in the Zinc sulphate solution for 30 seconds. The gel was rinsed 
with DDI water and put on a black background in order to see the bands. 
2.5.2. Western Blotting 
Samples in the 2x Lamemli sample buffer (Sigma Aldrich) were heated at 100°C for 8 
minutes, centrifuged and run in SDS-PAGE agarose gels. Proteins were transferred to a 
PVDF membrane (Millipore) using an electroblotting procedure. Membranes were blocked 
for Ih in 5% milk (TTBS) and then incubated with the antibodies, diluted in blocking 
solution, for different times. Membranes were washed with TTBS and incubated for 1 h 
with HRP conjugated secondary antibodies, diluted in 5% milk (TTBS). The presence of 
the proteins was revealed using Enhanced ChemiLuminescence (ECL). Antibodies are 
listed in Table 2.2. 
63 
PRIMARY ANTIBODIES 
a- HA HRP (clone HA-7, Sigma-Aldrich) 
a-T7 (Millipore) 
a-PCNA (clone I G7, Sigma-Aldrich) 
a-ubiquitin (clone P40 I, Cell Signalling) 
a-ubiquitin biotin conjugated (clone P401, Abeam) SECONDARY ANTIBODIES 
a-GAPOH HRP (clone 7.1.1., Sigma-Aldrich) a- Mouse IgG- HRP (Sigma-Aldrich) 
a-C I orfl24 (clone E6, 03, GenScript) (1- Rabbit IgG-HRP (Cell Signalling) 
a-yH2AX (clone JBW30 I, Millipore) 
Table 2.2. Antibodies used in this project. 
2.5.3. Mass Spectrometry 
SAMPLE PREPARATION FROM SDS-PAGE- Bands were cut from acrylamide gel 
and supplemented with 50 mM Ethylenediaminetetraacetic Acid EDT A (ph 8.0) for 15 
minutes. Samples were then reduced with 2.5 mM OTT in 20 mM DiAmmonium 
Phosphate pH 8.0 (di-AP), and incubated at 60°(' for 30 minutes. Followed by alkylation 
with 200 mM iodoacetamide for 1 hour in the dark. Gel slices were washed 3 times for 20 
minutes with 1 mL 501% MeOH containing 20 mM di-AP. To dry the pieces, 100 ilL of 
100% ACN was added. At the end, all dried sl ices were soaked with 10 ilL of Trypsin (10 
ng/IlL in 20 mM di-AP) for 25 minutes at 3rc. When the trypsin was absorbed, pre-
warmed di-AP was added just to cover the gel. Samples were kept overnight at 37°C. 
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SAMPLE PREPARATION FROM BEADS - After the IP or the OTAP, the beads were 
washed three times with PBS and trypsin (10 ng/ ~L) was added to just cover the beads. 
Samples were incubated at 37°C for 6 hours. Supernatants were removed and transferred to 
new tubes. Beads were washed twice with PBS and pooled together. In addition 1 0 ~L of 
trypsin was added and the samples were incubated for I hour at 50°C. 
DIGEST CLEAN UP PROTOCOL -After the trypsin digestion, samples were purified 
using the stage-tip method (Rappsilber et aI., 2(03). Digested supernatants were placed in 
new tubes. 5% of Formic Acid was added to the remaining gel pieces and the samples were 
sonicated for 15 minutes. The filter of the zip tips were wetted with 100% ACN and then 
1 0 ~L of 0.2% TF A was passed through the fi Iters. Then the samples were pushed through 
the column tips. Filter were washed with 50 ~L of 0.2% TFA and samples were eluted with 
1 0 ~L of a mix composed of 50% ACN and 50% TFA 0.2%. 
MASS SPECTROMETRY ANALYSIS - Samples were analysed with an ion trap mass 
spectrometer (Bruker). This mas spectrometer uses an electrospray ionization (ESI) source 
coupled to a Proxeon NANO LC system. Gradient were developed using ACN from I % to 
50% over a 90 minute period. LC-MS/MS spectra were searched against the human protein 
database by the GPM interface to the X!Tandem algorithm (Craig et aI., 2004). 
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3. AIM OF THE PROJECT 
Ubzl is the least characterized UBZ containing protein and recently it has been 
demonstrated to be involved in DNA repair. To further characterize Ubzl I decided to 
organize this thesis into two parts. In the first half of my thesis I describe the Ubzl post-
translational modifications and its SprT domain-dependent autocleavage. Specifically, I 
have used an approach based on mass spectrometry coupled with western blotting analysis 
to evaluate Ubzl ubiquitination and to analyze peptides derived from Ubzl degradation. In 
the second part of my work, I evaluated the lJbzllPCNA interaction by the creation of 
three PCNA constructs, which expressed peNA unmodified or fused with mono- or tetra-
ubiquitins. I made use of site directed mutagenesis in order to obtain Sprt and UBZ domain 
mutants, which were then used in many of these experiments. 
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4. RESULTS 
4.1. Ubzl Characterization 
4.1.1 Ubzl Post-translational Modifications 
Ubiquitination is a post-translational modification that involves the carboxy-
terminal Glycine of ubiquitin and the side chain of a Lysine of the target protein. Ubiquitin 
monomers can be assembled to form poly-ubiquitin chains. One feature of the UBZ family 
of proteins is that they can undergo UBZ-dependent ubiquitination. Therefore, UBZ 
domain containing proteins are both non-covalently bound to ubiquitin through their 
ubiquitin binding domains and are subjected to a covalent ubiquitination. This 
ubiquitination requires an intact ubiquitin-binding domain, in a phenomenon known as 
coupled ubiquitination (Bish et aI., 2008; ~Ioeller et aI., 2006). 
Since Ubzl has a UBZ domain (residue 453-476), I thought that it would also be 
subject to coupled ubiquitination. In order to test this feature, I performed a Oenaturing-
Tandem Affinity Purification COT AP) of wild type Ubz 1 and a version with a mutant UBZ 
domain. As reported for WHIP, the Alanine suhstitution of the highly conserved Aspartate 
in the UBZ domain abolishes the ubiquitin binding (Bish et aI., 2008; Hoeller et aI., 2006). 
These Ubzl constructs have a double tag, which consists of a HemAgglutinin (HA) 
epitope followed by a Metal Affinity Tag (MAT). OTAP consists of two-step purification: 
first a non-denaturing immunoprecipitation, which is based on the HA antibody linked to 
agarose beads. This is followed by a second step of denaturing purification, in which the 
proteins are released from the HA-antibody by the addition of a chaotropic agent, such as 
urea. Subsequently, Ni-NTA beads are incubated with the eluted material, where the 
immobilized nickel binds the MAT tag (Bish et al., 2008) (Figure 4.1). lover-expressed 
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HA-MAT-Ubzl WT and D473A Ubzl mutant in HEK293T cells and I performed DTAP 
purification 48 hours post-transfection. 
@~ HA bead 
Figure 4.1. Denaturing Tandem Affinity Purification procedure (DTAP). The DTAP protocol consists of two steps: 
an immunoprecipitation against an epitope tag under non-denaturing conditions, followed by a denaturing purification 
using a Ni-NTA matrix, which binds a tandem metal affinity tag. The goal of this purification is to obtain proteins from 
their native environments with intact post-translational modifications in the absence of non-covalently interacting protein 
partners. 
Subsequently, the DTAP purifications were analysed by western blot and I saw that 
the anti-HA blot of the over-expressed Ubzl WT appeared as a smear (Figure 4.2, lane 2), 
while the D473A was a single band (Figure 4.2, lane 3). In particular, both HA-MAT-
Ubzl ran between 50 and 75 kDa and the percentage of unmodified Ubzl WT was greater 
, than 85%. 
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HA-MAT-Ubzl WT D473A 
250-
anti- HAHRP 
HA-MAT-Ubzl 
2 3 
Figure 4.2. DTAP purifications of the HA-MAT-Ubzl WT and D473A samples. [mmunoprecipitated samples were 
run on a gel and blotted with the anti-HA HRP antibody. Wild type Ubz l ran as a smear whereas the D473A mutant ran 
as a unique band. 
Given these results, I thought that the smear might correspond to the ubiquitinated 
form of Ubzl and to gain further insights into the ubiquitination of the wild type Ubzl , I 
blotted the same samples with a anti-ubiquitin antibody, but I was not able to obtain a 
convincing blot. Therefore, I decided to make use of mass spectrometry analysis to identify 
the ubiquitinated peptides in the Ubzl purifications. To do this, lover-expressed HA-
MAT-Ubzl WT and D473A in HEK293T cells and after 48 hours, lysates were collected 
, and Ubzl was immunoprecipitated using anti-HA beads. In order to elute the specifically 
bound proteins, I incubated the bead bound immune-complexes with a high concentration 
of HA peptide diluted in lysis buffer. The HA peptide competes for the binding to the 
immobilized antibody, allowing the release of the HA-immune-complexes. I analyzed a 
portion of the samples by SDS-PAGE and visualized the eluted proteins by zinc staining. 
Finally, I processed the bands for analysis by LC-MS/MS. The LC-MS/MS analysis has a 
key weakness in that the mass spectrometer almost always undersamples the actual peptide 
content. In this case, I have summed the data from three runs in order to maximize the 
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coverage. 
As mentioned before, ubiquitin binding proteins are commonly subjected to the 
phenomenon known as coupled ubiquitination, which requires an intact ubiquitin-binding 
domain. For example, WHIP was found to he subjected to coupled ubiquitination and this 
ubiquitination is strictly dependent on the presence of the Aspartate residue in its UBZ 
domain (Bish, Fregoso et al. 2008). 
Peptides obtained from mass spectrometry analysis were counted and I found that 
despite the fact that the total number of Ubzl peptides were very similar, the number of 
ubiquitin peptides in the Ubzl WT was greater than in the UBZ domain mutant (D473A) 
sample (Table 4.1). This result, together with the data from the western blot analysis, 
suggests that Ubzl might subjected to coupled ubiquitination, because this ubiquitination 
is strictly dependent on its UBZ domain. Thus my data are consistent with previous results, 
which also reported that the substitution of Aspartate at position 473 in UBZ domain of 
Ubzl abolishes the ubiquitin binding (Machida et ai., 2012). 
Ubzt TYPE TOTAL Ubzt UNIQUE Ubzt TOTAL Ub UNIQUE Ub 
WT 2212 186 34 1 1 
D473A 2043 200 5 3 
Table 4.1. Ubiquitin pep tides from HA-MAT-Ubzl WT and 1)473A purifications. HA-MAI-Ubzl WT and D473A 
were purified with the IIA beads and eluted with the IIA peptide. Immune-complexes \\ere then digested with the trypsin 
and peptides were analysed by LC-MS/MS. llere the total and unique peptides for ubiquitin found in the analysis arc 
reported. Total=total number of peptides identified. Unique peptide~a peptide with unique individual amino acids 
sequence is counted a single time regardless of how many times the mass spectrometer detected it. Ilcre I report the 
number of peptides identified with a unique amino acids sequenu: f()r lJbz I and ubiquitin. 
At this point, I decided to blot the eluted HA-MAT-Ubzl WT and D473A with the 
anti-ubiquitin antibody and I was able to detect the smear of ubiquitinated Ubz I WT 
(Figure 4.3, lane 2), which I could not see in the DTAP purification. As reported in Figure 
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4.3 (lane 3, long exposure), only a weak band corresponded to mono-ubiquitinated Ubzl 
was visible in UBZ domain mutant, indicating that the mutant was ubiquitinated at a much 
lower level then WT (lane 2), confirming the results shown in the blot in Figure 4.2. The 
anti-HA HRP blot in Figure 4.3 (lower panel, lane 2) showed that the HA-MAT-Ubz1 WT 
was ubiquitinated. 
HA-MAT- Ubz l 
Light 
exposure 
7 
50-
75 
WT D473A 
2 3 2 3 
Long 
exposure 
anti- Ubiquitin 
anti- HAHRP 
Figure 4.3. Ubzl WT ubiquitination. HA-MAT-Ubz l WT and D473A were expressed in HEK293T cells, purified and 
eluted with the peptide. Samples were blotted with the anti-ubiquitin antibody and with anti-HA HRP antibody. 
Samples analysed by LC-MS/MS also revealed the sites In Ubz1 that are 
ubiquitinated. The three C-terminal residues of the ubiquitin monomer are Arginine-
Glycine-Glycine and the last C-terminal Glycine is conjugated to the Lysine of the protein 
target. Trypsin cleaves after Lysine and Arginine residues, but when Lysine residues are 
modified with ubiquitin, the tryptic cleavage leaves a di-Glycine tag, which shifts the mass 
of the peptide by 114.1 Da. Thus, peptides modified by ubiquitin can be identified both by 
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the Increase In the mass and often by a missed cleavage at the ubiquitinated Lysine. 
Analysing the samples by LC-MS/MS revealed four Ubzl peptides that were 
ubiquitinated and the annotated spectra of their modified forms are reported in Figure 4.4 
(panel A) with their specific sites that are listed in Figure 4.4 (panel B) and are represented 
by a cartoon in Figure 4.4 (panel C). Interestingly, I noticed that all of the modified 
Lysines were located between the PIP box motif and the UBZ domain, but none of these 
four residues was positioned in any particular annotated domain, even if the first one, in 
which K341 is ubiquitinated, is situated 9 amino acids downstream of the PIP box motif 
(Figure 4.4, panel B and C). 
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352-361 ISVTVGNIPK 361K(114.1) Log 10 (-4.8) 
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HA MAT 
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Figure 4.4. Ubzl ubiquitin peptides. By LC-MS/MS analysis, four peptides from Ubzl were found to carry the 
ubiquitin mark and the modified Lysine residues are reported. Panel A contains the annotated spectra for the modified 
Ubzl peptides. Panel B contains a table of the match statistics for these peptides. The E-values of these peptides were 
low, indicating that they were not random matches. Panel C shows a schematic representation of Ubz I. Ubz 1 contains 
489 amino acids. The Sprt domain is situated at the N-terminus (45-213 residue), whereas the PIP box motif is closer the 
C-terminus (325-332 residue) and the UBZ domain is at the C-terminus (345-476 residue) of Ubzl sequence. The four 
, Lysine residues modified with ubiquitin are coloured in red. 
The smear of ubiquitinated Ubzl that I detected in Figures 4.2 and 4.3 corresponds 
to either a multiple, mono-ubiquitinated or a poly-ubiquitinated form of Ubzl. Since LC-
MS/MS analysis revealed one ubiquitin peptide in the HA-MAT-Ubzl purification that 
was ubiquitinated at Lysine 48, I thought that it was likely to be poly-ubiquitinated. This 
hypothesis was strengthened by the results that I obtained when I treated the transfected 
cells with proteasome inhibitor. 48 hours after transfection, I treated the HEK293T cells 
with the MG 132 proteasome inhibitor. After a further 4 hours, I collected the cells and I 
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immunopurified HA-MA T-Ubzl as described above. The HA peptide eluted samples were 
blotted with the anti-ubiquitin antibody and as shown in Figure 4.5, the level of 
ubiquitinated Ubzl greatly increased upon treatment. This demonstrates that the 
ubiquitinated Ubzl is degraded by the proteasome and further confirms the finding by LC-
MSIMS that the Ubzl carries poly-ubiquitin chains linked at K48. In the anti-HA HRP blot 
two bands for HA-MAT-Ubzl are visible, which probably correspond to the unmodified 
and mono-ubiquitinated form ofUbzl (Figure 4.5, bottom panel). 
HA-MAT-Ubz l 
MG I32 
75-
WT 
2 
+ 
3 
WT 
+ 
4 
anti- Ub 
anti- HA HRP 
Figure 4.5. Ubzl poly-ubiquitination. HA-MAT -Ubz I WT was expressed in HEK293T cells. After 48 hours, cells were 
treated with MG 132 for an additional 4 hours. Ubz 1 was HA purified, eluted with the peptide and blotted with the anti-
ubiquitin antibody. Anti-HA HRP antibody was used as a control. 
4.1.2. Ubzl Autocleavage 
I also noticed that when analysed by SDS-PAGE and western blot, in addition to 
the 55 kDa full length HA-MAT-Ubzl , other immune-reactive bands were also present. 
75 
The upper band in the WT HA-MAT-Ubzl most likely corresponds to the mono-
ubiquitinated form of Ubzl , but there were abundant bands detected between 25 and 50 
kDa, as shown in Figure 4.6. 
HA-MAT-Ubz l 
50-
37-
25-
20-
15 
10 
WT D473A 
~----------------~ 
anti- HAHRP 
20-25 kDa 
2 
Figure 4.6. Ubzl degradation bands. HEK293T cells were transfected with HA-MAT-Ubz l WT and D473A. Samples 
were HA purified and eluted with the HA peptide. Immonoprecipitations were blotted with the anti-HA HRP antibody. 
The yellow square indicates the portion of the gel between 20-25 kOa. 
I thought that the lower bands might correspond to degraded forms of Ubzl. To 
investigate this further, I immunoprecipitated HA-MAT-Ubzl WT and I eluted the 
immune-complexes with the HA peptide. I ran the samples on a gel, and various regions of 
the gel were digested and analyzed by LC-MSIMS. Since the HA-MAT-Ubzl constructs 
are N-terminally tagged and HA purified, the degradation products should also contain the 
N -terminus. 
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I divided the full-length sequence into N-terminal, middle and C-terminal bins and I 
determined the percentage of the peptides coming from each of the three bins. Assuming 
that the N-terminus was intact, the three regions would correspond to a band up to 30 kDa 
for the N-terminal region, the middle region up to 40 kDa and the C-terminal region up to 
55 kDa, Figure 4.7 (panel A). The table in Figure 4.7 (panel B) shows the number of total 
Ubzl peptides that I found in each band. I saw that the bands corresponding to the full-
length Ubzl contained peptides that cover the entire sequence of the protein and the bands 
around 37 kDa had a higher amount of peptides belonging to the N-terminal region of 
Ubzl. Unexpectedly, the highest percentage of C-terminal peptides was obtained from the 
lowest band of around 20 kDa (Figure 4.7, panel C and Figure 4.6, yellow square). Since I 
immunoprecipitated the samples with anti-HA beads, and the HA tag was at the N-
terminus of Ubzl , the fact that some peptides identified in the elution were part of the C-
terminal region of Ubzl suggests that Ubzl was being cleaved during its purification. In 
fact, if Ubzl had been cleaved before its immunoprecipitation, I should not have found 
Ubzl peptides coming from its C-terminus. 
A 
SPRT PIP UBZ4 
N C 
HA 
25-30 kDa N C 
HA 
30-40 kDa N C 
HA 
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B 
TOTAL NUMBER OF Ubz1 
BAND'S SIZE PEPTIDES 
20-25 kDa 346 
37kDa 326 
37> kDa 504 
FULL LENGTH 977 
c 
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Figure 4.7. Analysis of HA-MAT-Ubzl cleavage products. HA-MAT-Ubzl was immunopurified and then analyzed by 
SDS-PAGE. Bands were stained with colloidal Comassie blue, cut and digested with trypsin. Samples were then analysed 
by LC-MS/MS. Cartoons of full length HA-MA T-Ubzl, 25-30 kDa, 30-40 kDa and 40-55 kDa Ubzl are shown in panel 
A. Panel B reports the number of peptides found in each band. The graph in panel C shows the percentage of peptides 
coming from the N-terminal, middle and C-terminal ofUbzl sequence. 
As previously noted, Ubzl IS the least characterized UBZ domain-containing 
protein. In addition to the UBZ domain, Ubz 1 also contains a PIP box motif and an Sprt 
domain. The Sprt domain ofUbzl contains a HExH motif that is highly conserved from E. 
coli to humans and is similar to some zinc-dependent metalloprotease catalytic sites in 
which the zinc molecule is coordinated by two Histidines residues and a Glutamate 
residue. A water molecule acts as a nucleophile during catalysis (Jongeneel et ai., 1989). 
Thus, I thought that the Sprt domain of Ubz 1 might act as a metalloprotease, and mediates 
its own cleavage. To test this hypothesis, I analysed the behaviour of two Sprt domain 
mutants of Ubzl. I used site-direct mutagenesis to create two mutants of this domain; 
Glutamate at the position 112 of Ubzl, was substituted with an Alanine giving an Sprt 
domain single mutant (EI12A), while in the Sprt double mutant, the Histidine 111 was 
substituted with Leucine residues in conjunction with the Glutamate substitution 
(H 111 LIE lI2A). When I analysed these Sprt mutants by western blot, I saw that the 
quantity of degradation bands was greatly reduced in the E lI2A mutant and virtually 
undetectable in the HIll LIE l12A double mutant (Figure 4.8, lanes 3 and 4). 
Given that the Sprt domain mutant showed reduced levels of degradation, plus the 
finding of C-terminal peptides in the HA-MA T-UbzI immunopurification and the fact that 
the sites of SprT domain mutagenesis were far away from the cleavage sites, it is 
reasonable to suggest that the Sprt domain mediates the cleavage of Ubz 1. 
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Figure 4.8. The HExH motif is required for Ubzl degradation. HA-MAT-Ubzl WT, D473A, E I12A and 
H III LIE 112A were expressed in HEK293T cells and Iysates were blotted with the anti-HA HRP antibody. 
4.2. Ubzl Binds PCNA 
4.2.1. Endogenous PCNA 
PCNA plays an important role in DNA replication and repair. As a matter of fact, it 
acts as a DNA polymerase processivity factor, tethering DNA polymerases onto DNA 
strands and when the replication fork stalls upon DNA damage, it can be mono or poly-
ubiquitinated. 
Many proteins posses a PCN~ interacting motif (PIP box), which mediates their 
interaction with PCNA. Three UBZ containing proteins posses a PIP box: polymerase 11 
(Haracska et aI. , 2001), polymerase K (Haracska et aI. , 2002) and SNM1A (Yang et aI., 
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20 I 0). As Ubz 1 also contains a motif that matches the PIP box consensus sequence 
(residues 325- 332), I thought that it might also bind peNA. To test this, I decided to 
transfect HEK293T cells with the HA-MAT-Ubzl plasmid and HA-MAT-Ubzl protein 
was then immunopurified and eluted with the HA peptide. HA-MAT-Ubzl WT co-
immunoprecipitated with endogenous peNA. while the EGFP protein, which was used as a 
negative control, did not, as shown in Figure 4.9 (panel A, lane 1). In addition, I noticed a 
second, higher molecular weight peN A band that also co-immunoprecipitated with HA-
MAT-Ubzl (panel A, lane 2, panel B, lane 1). It is not clear if that band correspond to the 
mono or di- ubiquitinated peNA, but only the mono-ubiquitinated peNA has been 
reported in literature (Hoege et aI., 2002), I thought it was consistent with the predicted 
molecular weight of mono-ubiquitinated peNA. In fact, since the predicted molecular 
weight of peNA and ubiquitin monomer are 29 kDa and 8.5 kDa, respectively, the mono-
ubiquitinated peNA should run around 37 kDa. Moreover, we did not detect ubiquitin 
peptides modified on internal linkages, K48 for example that would indicate 
diubiquitination. 
Since I already found that Ubzl is subjected to coupled ubiquitination, which also 
happens to WHIP and PolT], whose UBZ domains binds ubiquitin, I thought that the UBZ 
domain of Ubz 1 might also bind ubiquitin. ThercfiJre, in order to test if this domain might 
contribute to the interaction between Ubzl and the modified form of peNA, I decided to 
check whether the UBZ mutant retains the capacity to bind the modified form of peNA. 
Therefore, lover-expressed the HA-MAT-Ubzl D473A mutant in HEK293T cells and I 
purified Ubzl from the whole cell extracts. When I blotted the HA purified immune-
complexes, I saw that the UBZ domain mutants retained the capacity to bind the 
unmodified but not the modified forms of peNA, which I predicted to be mono-
ubiquitinated peNA, strengthening the hypothesis that this modification corresponds to 
ubiquitin. Nevertheless, when I immunopurified the UBZ domain mutant of Ubz 1, a 
modified form of peNA with a molecular weight very close to the unmodified form of 
81 
PCNA was detected, as shown in Figure 4.9 (panel B, lane 2), but the identity of this band 
is unknown. Moreover, as is visible in Figure 4.9 (panel B, lane 2, bottom panel), the UBZ 
domain mutant of HA-MAT-Ubzl presents as only one band, which corresponds to the 
unmodified form of Ubzl, whereas the WT and the other mutants of Ubz 1 showed a band 
of unmodified Ubzl and an ubiquitinated form of Ubzl. These data are consistent with 
recent published results, in which it has been demonstrated that Ubz 1 has a functional UBZ 
domain that directly binds ubiquitin (Centore ct aI., 2012). 
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Figure 4.9. Ubzl co-immunoprecipitates with peNA. HA-MAT-Ubzl WT, D473A, EI12A or Hll1LlE112A were 
expressed in the HEK293T cells and HA-purified. In panel A are shown the IPs of the negative control (EGFP), WT and 
H III LIE 112A blotted with the anti-PeNA antibody (high panel). Whole cell lysates were blotted with the anti-PeN A 
antibody as a control (lower panel). In panel B are shown IPs of WT, D473A, EI12A and HIIILlEI12A blotted first 
with anti-PeN A antibody and then with anti-HA HRP antibody. 
It has recently been reported that the PIP box motif mediates the interaction 
between Ubz1 and PCNA (Centore et aI., 2012; Davis et aI. , 2012; Ghosal et al., 2012; 
Juhasz et aI., 2012; Machida et aI., 2012; Mosbech et aI., 2012). In addition, my data 
demonstrate that Ubz1 interacts with PCNA and that the UBZ domain is indispensable for 
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the interaction with the ubiquitinated form of rCNA. 
Given that both the PIP box motif and the UBZ domain are important for 
Ubz1/PCNA interactions, I decided to verify whether the SprT domain of Ubz1 could also 
playa role in PCNA binding. Therefore, I decided to over-express the single Sprt mutant 
HA-MAT-Ubz1 (E112A) and the double Sprt mutant HA-MAT-Ubz1 (HIIIL1El12A) in 
the HEK293T cells. I subjected the lysates to the immunopurification with anti-HA beads 
and I analyzed the immune-complexes by western blotting. Surprisingly, I saw that the 
E lI2A Ubzl mutant had reduced interactions with rCNA (Figure 4.9, panel B, lane 3). 
and the interaction between HIlI LIE 112A mutant and rCNA was almost undetectable 
(Figure 4.9 panel A, lane 3 and panel Blane 4). 
Since the HA-MAT-Ubzl El12A and I1111L1E112A mutants have a weaker 
interaction with peNA, I thought that the SprT domain might affect PCNA/UbzI 
interaction. To investigate this further, I digested a portion of HA purified HA-MAT-Ubzl 
WT and the Sprt double mutant (H III LIE 112A) with trypsin and analysed those samples 
by LC-MS/MS. Using this approach, I found peNA peptides in both the HA-MA T -Ubzl 
WT and the Sprt double mutant H III LIE 112A samples. This could have been due to the 
fact that by mass spectrometry we analysed the entire quantity of peptides contained in the 
immunoprecipitated samples, whereas in the western blots the same samples were 
widespread throughout the gel and therefore more diluted, when detected with the 
antibody. However, I only found evidence of ubiquitination of rCNA in the WT samples 
(Table 4.2). In particular, I saw that PCNA was ubiquitinated at K 164. 
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UBIQUITINATED 
Ubzl TYPE UNIQUE PCNA TOTALPCNA PCNA 
WT 6 19 K164 
HIlI LIE 1 12A 2 14 0 
Table 4.2. Ubiquitinated PCNA from HA-MAT-lJbzl WT and HIli LIE 112A purifications. HA-MAT-lJbz I WT 
and 11111 LIE 112A were purified with the IIA beads. Immune-mmplexes were then digested with trypsin and peptides 
were analysed by LC-MS/MS. Here the total and unique peptides for PCNA found in the analysis arc reported. The site 
of PCNA uhiquitination is reported in the forth column. 
Even though I was not able to demonstrate that the higher band of PCNA is 
ubiquitinated by western blot, the mass spectrometry results are consistent with the higher 
molecular band of modified PCNA being mono-ubiquitinated form of PCNA. 
K 164 of PCNA is the residue where RAD6!RADI8 ubiquitinate PCNA following 
UV damage. However, it has been reported that a fraction of PCNA appears to be 
constitutively ubiquitinated at low levels in some cell lines, including the HEK293T cells, 
even in absence of DNA damage (Chiu et aL 2006). Since my data indicate that Ubzl 
binds both the modified and the unmodified form of PCNA, I thought it would be 
advantageous to find a way of mimicking the situation in which PCNA was permanently 
ubiquitinated. Therefore, I decided to build three difTerent plasmids that I will discuss in 
the next section. 
4.3. PCNA Fusion Proteins 
4.3.1. Construction of PCNA Fusion Proteins 
Endogenous metabolic processes and environmental factors continuously damage 
genomic DNA. If the replication fork comes across a DNA lesion, the high fidelity 
polymerases stall because their active sites are not able to accommodate damaged bases. 
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Fork stalling can result in the mono-ubiquitination of PCNA at K 164, which recruits the 
low fidelity UBZ domain containing DNA polymerases (Bienko et aI., 2005; Hoege et aI., 
2002). 
In order to reproduce the situation 111 which PCNA is mono-ubiquitinated, I 
generated a plasmid expressing HA-MAT tagged PCNA fused to mono-ubiquitin at the N-
terminus (HA-MAT-Ub-PCNA) (Figure 4.10). Ramasubramanyan et aI., performed 
different experiments in S. pombe, in which they fused a single ubiquitin molecule to the 
N-terminal end of PCNA. They demonstrated that the fusion protein was expressed at 
similar levels to the endogenous PCNA and that it mimicked the effects of mono-
ubiquitinated PCNA. In particular, the Ub-PCNA fusion protein was still able to form a 
trimeric complex with the endogenous PCNA; moreover, yeast in which the K 164 of 
endogenous PCNA was mutated, were still able to survive upon UV -irradiation when they 
were transformed with the Ub-PCNA construct (Ramasubramanyan et aI., 2010). Other 
experiments were performed in S. cerevisae, that revealed that the position of ubiquitin on 
PCNA was irrelevant for the interaction with the polymerase TJ (Parker et aI., 2007). 
Similarly, in order to reproduce the conditions where PCNA is poly-ubiquitinated, I 
cloned a tetra-ubiquitin fusion to PCNA (Figure 4.10). Ub-PCNA constructs were 
synthetized chemically by Genescript and the cDNAs were inserted into the pCGN-MA T 
vector. In pHA-MAT-Ub-PCNA, the N-terminal Methionine of PCNA was deleted in 
order to avoid the ubiquitin-specific proteases that would otherwise cleave the fusion 
protein, whereas in pHA-MAT-4Ub-PCNA, the N-terminal Methionine of the ubiquitins 
were substituted with Prolines and the N-terminal Methionine of PCNA was deleted. 
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Figure 4.10. HA-MAT-PCNA fu sion proteins. Cartoon of the PCNA fusion proteins. PCNA, Ub-PCNA and 4Ub-
PCNA were cloned into pCGN-MAT resulting in epitope tagged versions. In order to suppress the cellular cleavage of 
the ubiquitin moiety the N-terminal Methionine of pe NA was deleted, whereas in HA-MAT-4Ub-PCNA the N-terminal 
Methionines between the four ubiquitins were also mutated to Pro lines. 
In this thesis, I will call the three constructs that I built, PO (HA-MA T -PCNA), PI 
(HA-MAT-Ub-PCNA) and P4 (HA-MAT-4Ub-PCNA). 
4.3.2. Verification of PCNA Constructs 
Once I obtained the three PCNA constructs, I decided to verify that the three PCNA 
fusion proteins were expressed. To do this, I transiently transfected l)..lg of the three PCNA 
plasmids into the HEK293T cells and I analysed the whole celllysates by western blotting 
with anti-PCNA antibody. I saw that all the fusion proteins were expressed, as reported in 
Figure 4.11 (panel A). In particular, PO was approximately the same size as endogenous 
PCNA and P4 showed four bands, which probably correspond to the mono- di- or tri-
ubiquitinated PCNA, labelled as PI , P2 and P3 (Figure 4.11 , panel A, lane 4). All the 
forms of PCNA were easily detected when immonoprecipitations were blotted with the 
anti-HA HRP antibody, and if PI ran as a weaker band, as shown in Figure 4.11 (panel B, 
lane 3). Moreover, PI showed an additional band that seemed to have the appropriate size 
ofHA-MAT-UB (Figure 4.11 , panel B, lane 3), whereas P4 showed four additional bands, 
which might correspond to the HA-MAT-Ub, HA-MAT-di-UB, HA-MAT-tri-UB and HA-
MAT -tetra-UB (Figure 4.11 , panel B, lane 4, indicated with asterisk), but in order to verify 
that these bands are HA-MAT-ubiquitin isoforms, I would need to perform LC-MS/MS on 
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the various gel bands. With these data I confirmed that all of the peNA constructs were 
expressed. Since PI ran as a weaker band, I thought that it might mean that either PI was 
less expressed than PO and P4 or that PI was more rapidly degraded then PO and P4. 
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Figure 4.11. Verification of peNA constructs. PO, P I and P4 were expressed in the HEK293T cells and HA purified. 
In panel A the Iysates of PO, P I and P4 blotted with the anti-PeN A antibody are shown. In panel B an 
immonoprecipitation of PO, P I and P4 blotted with the anti-HA HRP antibody is shown. 
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Given that PCNA is mono-ubiquitinated upon DNA damage, I decided to test if 
expression of PI could be a signal of DNA damage. As I described in paragraph 1.1 , upon 
DSBs, H2AX is phosphorylated by the kinases A TM and ATR. Since the phosphorylated 
H2AX is a sensitive target for DSBs in cells, I decided to use the yH2AX antibody to 
check if expression of the three PCNA constructs would result in increasing levels of 
A TMI A TR signalling. I blotted lysates from cells expressing PO, PI and P4 with the anti-
yH2AX antibody. As shown in Figure 4.1 2, I detected the strongest band of yH2AX in 
HEK293T cells that were treated with UV. A band of similar intensity of those of 
HEK293T cells treated with UV was visible for PI and a less intense band was visible 
from the cells expressing PO. In contrast, I did not detect an increasing of the level of 
yH2AX in P4 sample. 
uv + 
HA-MA~PCNA.-_________ P_O ______ P_I ______ P_4 __________ -. 
LYSATES 
anti- yH2Ax 
anti- GAPDH 
2 3 4 5 
Figure 4.12. PI expression activates a DNA damage signal. PO, PI and P4 were expressed in the HEK293T cells and 
Iysates were blotted with anti-yH2AX and anti-GAPDH (loading control). 
These results demonstrate that all of the PCNA constructs were expressed and that 
PI increased the level of yH2AX, which indicates the activation of a DNA damage signal 
in the cells expressing PI. The band of y H2AX detected for PO was likely the result of the 
mono-ubiquitination ofHA-MAT-PCNA (Figure 4.11 , panel A, long exposure, lane 2, red 
square), which could serve to increase the level of the damage signal. 
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4.4. Ubzl and Ub-PCNA Co-expression 
RAD6/RADI8 act together in ubiquitinating PCNA at KI64 in response to DNA 
damage (Hoege et aI., 2002) and recently the RAD I8-dependent PCN A mono-
ubiquitination has been reported to be indispensable for UbzI localization at damage foci 
(Centore, Yazinski et al. 2012). In fact, it has been shown that UbzI is recruited to the sites 
of damage in a manner dependent on both the PIP box motif and the UBZ domain 
(Machida, Kim et al. 2012; Centore, Yazinski et al. 2012). 
In the first part of my results, I demonstrated that endogenous PCNA co-
immunoprecipitates with HA-MAT-UbzI. To further characterize the UbzllPCNA 
interaction, I decided to make use of the PO, PI and P4 constructs as a model to reproduce 
the situation in which PCNA is unmodified, mono-ubiquitinated or poly-ubiquitinated. In 
the previous experiments I utilized UbzI and peN A plasmids with the same HA-MA T tag, 
so I decided to clone PCNA, Ub-PCNA and 4lJb-PCNA into a T7 vector and I will call 
them T7-PO, T7-Pl and T7-P4. The pCGT7 vector derived from the pCG vector in which 
the 11 amino acid-T7 tag was inserted (MASMTGGQQMG). 
In order to characterize the UbzllPCNA interactions, I co-transfected HA-MAT-
Ubzl WT with the T7-PO, T7-PI and T7-P4 constructs. I immunoprecipitated Ubzl and 
then I blotted the immune-complexes with the anti-T7 antibody. As shown in Figure 4.13, I 
observed that T7-PO and T7-P4 were easily visible and that those bands had a strong 
intensity, whereas T7-PI band was not detectable at all. 
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Figure 4.13. Co-expression of T7-PI and Ubzl results in a loss in T7-PI immunoreactivity. T7-PCNA constructs 
were co-expressed with HA-MAT-Ubzl in HEK293T cells. Lysates were HA purified and blotted with the anti-T7 and 
anti-HA HRP antibodies. 
To investigate the fate ofT7-P1, I decided to blot the imrnunopurified samples with 
an antibody against peNA (Figure 4.14) and I saw that this antibody recognized bands of 
the appropriate size for T7-PO and T7-P4 and a band very close to the molecular weight of 
T7-PO in the imrnunoprecipitation from the cells transfected with T7-Pl. 
HA-MAT-Ubz I 
TI-PCNA 
5 
37 
+ + + 
2 
+ 
P4 
"'!!I!!!!!!~. antibody heavy chain 
anti- PCNA 
3 4 
Figure 4.14. Ubzl co-purifies with a fragment ofT7-PI. T7-PCNA constructs were co-expressed with HA-MAT-Ubz l 
in the HEK293T cells. Lysates were HA purified and immunoprecipitations were blotted with the anti-PCNA antibody. 
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As shown in Figure 4.13 and 4.14, I did not detect full length PI but only a form 
that corresponds to the unmodified peNA. So I decided to subject a portion of these 
samples to Le/MS-MS analysis and I found peNA and Ubzl peptides in all of the 
immunoprecipitations, as reported in Figure 4.15 (panel A and B), whereas I detected 
ubiquitin peptides only in the T7-P4 samples and not in T7-PO or T7-Pl samples (Figure 
4.15, panel e). The lack of ubiquitin containing peptides 111 the T7-Pl 
immunoprecipiations was unexpected and these results indicate that both Ubzl and peNA 
were efficiently immunoprecipitated. However, ubiquitin peptides were only detected in 
the sample transfected with T7-P4, indicating that ubiquitinated peNA was absent or 
greatly reduced in the samples transfected with T7-PO and T7-Pl. Thus these data seemed 
to further support the results previously obtained from the western blot analysis. 
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Figure 4.15. LC-MSIMS analysis of HA-MAT-Ubzl and T7-PCNA co-immunoprecipitations. T7-PO, T7-P I and T7-
P4 were co-transfected with HA-MAT-Ubz l WT. Samples were immunoprecipitated with the anti-HA beads, tryptic 
digested and analysed by LC-MS/MS. In panel A the peptides for PCNA are reported, whereas panel B and C indicate 
the number ofUbz l and ubiquitin peptides, respectively. 
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4.4.1. Ub-PCNA Expression 
As previously shown in Figure 4.11 , the band corresponding to PI had a weaker 
intensity then those of PO and P4. Furthermore, I noted that when PO, PI and P4 
immunoprecipitations were blotted with the anti-HA HRP antibody, there was a lower 
band at - 10 kDa, in the PI samples and much less in P4 samples (Figure 4.11 , panel B, 
lanes 3 and 4). Since T7-Pl appeared to be cleaved in the blots shown in Figure 4.13 and 
4.14, I decided to check if increasing levels of Ubzl leads to an increasing intensity of 10 
kDa band. Therefore, I co-transfected HEK293T cells with 1 ~g ofT7-PO or T7-Pl and 0, 
1, 2, 3 ~g ofHA-MAT-Ubzl. When I collected the lysates and I blotted them with an anti-
T7 antibody, I saw that the intensity of the 10 kDa band of T7 -P 1 was directly proportional 
to the increasing level of HA-MAT-Ubzl that was co-transfected (Figure 4.16), whereas 
T7-PO always ran as a strong band of the appropriate molecular weight. 
T7-PCNA PO PI PO PI PO PI PO PI 
~lg HA·MAT·Ubz I r-O"----'O'--_--"-_--"-__ _=_2 _-=2'--_.....:3"-----=3'----, 
anti- T7 
anti- HA HRP 
anti- GAPDH 
2 3 4 5 6 7 8 
Figure 4.16. Tag-Vb-PeNA is cleaved to give rise to a 10 kDa band. T7-PO and T7-PI were co-transfected with 0, I, 
2, 3 Ilg of HA-MAT-Ubz l. Lysates were blotted with the anti-T7 antibody and with the anti-HA HRP antibody as a 
control. Asterisk indicates the 10 kDa band. 
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In order to characterize the 10 kDa band, I ran the PI immunopurifications on a gel 
and analyzed the bands by LC-MS/MS. This analysis revealed that the 10 kDa band in the 
PI immunopurifications was HA-MAT tagged ubiquitin, in fact it ended very near to the 
junction between ubiquitin and PCNA, shown in Figure 4.17. 
HA MAT 
I \ I 
MASSYPYDVPDYALGGPSR MQIFVKTLTGKTITLEVEPSDTIENVKAKIQ 
DKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLR GGMFEARLVQGS 
ILKKVL EALKDLI EACWDISSSGV LQSMDSSHVSLVQLTLRSEGFDTY 
RCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLM 
DLDVEQLGIPEQEYSCVYKMPSGEFARlCRDLSHIGDAVYISCAKDGVKFSASGELG GNI 
KLSQTSNVDKEEEAVTIEMNEPVQLTFALRYL FFTKATPLSSTYTLSMSADVPLVVEYK 
IADMGHLKYYLAPKJ EDEEG 
Figure 4.17. LC-MS/MS analysis of the 10 kDa band of PI. P I was HA purified and run on the acrylamide gel. The 
gel was stained with colloidal Comassie blue and the band around 10 kDa was analysed by LC-MSIMS. The resulting 
HA-MAT-Ub peptides are reported in red/green. The amino acid sequence corresponded to ubiquitin is shown in bold 
red. 
Since the band corresponding to the other part of PI would not be detectable with 
the anti-HA antibody and to gain further information about the fate of PI , I decided to also 
analyse the portion of the gel close to 37 kDa by LC-MS/MS analysis. Mass-spectrometry 
analysis indicated that the portion of the gel around 37 kDa contained PCNA, which was 
missing in HA-MAT-Ub fusion (Figure 4.18). 
HA-MAT-UB MASSYPYDVPDYALGGPSRHNHRHKHSRMQIFVKTLTGKTITLEVEPSDTIENVKAKI 
DKEGIPPDQQRLlFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMFEARLYQGS 
[
LKK VLEALKDLI N EACWD ISSSGVN LQSM D SSH vs LVQL TLR SEGFDTY 
peNA RCDRNLAMGVNLTSMSK CAGNEDIITLRAEDNADTLALYFEAPNQEKVSDYEMKLM 
DLDYEQLGIPEQEYSCYYKMPSGEFAR DLSHIGDAVVISCAKDGYKFSASGELGNGNI 
KLSQTSNVDKEEEAVTlEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVYEYK 
IADMGHLKYYLAPKJEDEEG 
Figure 4.18. LC-MS/MS analysis of the 37 kDa band of PI. PI was HA purified and run on the acrylamide gel. The 
gel was stained with colloidal Comassie blue and the portion of the gel around 37 kDa was analyzed by LC-MS/MS. 
Amino acids identified by LC-MS/MS are shown in red and the amino acid sequence corresponded to HA-MAT-Ub is 
shown in black bold_ 
Considering the results from the mass spectrometry analysis, in which I only found 
HA-MAT-Ub peptides in the 10 kDa band and PCNA peptides in the 37 kDa band and the 
previous finding, in which a PCNA band at the same level of the PO was found only when 
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PI, and not P4 was co-trans fee ted with UbzL I believe that the band that I detected for T7-
PI in the anti-PCNA blot originates from PI rather than from endogenous PCNA. 
4.4.2. Vbzl Mutants and Vb-PCNA Co-expression 
Since my results indicated that Ubz I has a metalloprotease activity and that Ubzl 
appears to cleave PI, I decided to investigate the fate of P I when co-expressed with 
different mutants of Ubzl. Therefore. I co-transfected 1 Ilg of T7-Pl with 9 Ilg of HA-
MAT-Ubzl WT or with the HIIIL1EI12A double mutant. HA-MAT-Ubzl WT and the 
double mutants were immunoprecipitated and eluted with the HA peptide. When I blotted 
these immune-complexes with the anti-'n IIRP antibody. as shown in Figure 4.19 (upper 
panel), I saw that the PI appeared as a weak band when co-transfected with the HA-MAT-
Ubzl WT (Figure 4.19, upper panel, lane 5). This band did not correspond to the expected 
molecular weight of PI, which should be around 50 kDa, but may correspond to a 
modified form ofPl. However, when T7-PI was co-transfected with the HIIILlEI12A 
mutant, I noticed that PI appeared as a smear of higher molecular weight forms (Figure 
4.19, upper panel, lane 6) that I thought might be poly-ubiquitinated forms of peNA. 
Expression of HA-MAT-Ubzl was confimled by blotting the same membrane with the 
anti-HA HRP antibody and as expected. both IIA-MAT-lJbzl WT and mutant were highly 
expressed. Again, unlike HA-MAT-lJbzl WT (Figure 4.19, bottom panel, lane 5), 
Hl1lLlEI12A mutant (Figure 4.19, bottom panel. lane 6). showed a weaker degradation 
activity. 
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Figure 4.19. PI smear. T7-PI was co-transfected with HA-MAT-Ubzl WT or H IIILlEI12A mutant. Samples were 
purified with HA beads and eluted with HA peptide. Immune-complexes were blotted first with the anti-T7 HRP 
antibody and then with anti-HA HRP antibody, as a control. Lysates blot is shown in lanes 1-3 . 
These results indicate that the T7-PI appears to have a different fate when it was 
co-transfected with the Ubzl SprT double mutant. In order to further investigate this, I 
performed the same co-transfection and I immunoprecipitated PCNA rather than Ubzl. I 
co-transfected 2 Ilg of T7-PCNA with 9 Ilg of HA-MAT-Ubzl and samples were 
immunopurified with anti-T7 beads and blotted first with anti-T7 HRP antibody, stripped 
and then re-probed with anti-HA HRP antibody. As shown in Figure 4.20 (upper panel, 
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lanes 7-9), T7-Pl showed the same bands when it was co-transfected with the empty 
vector, HA-MAT-Ubzl WT and Sprt double mutants. The pattern of PCNA in the T7-IPs 
was most likely the result of a pool of tagged PCNA that was not associated with Ubz 1 and 
this would account for the difference seen when Ubzl was immunoprecipitated and probed 
with T7 HRP antibodies. Notably, when the '1'7 immunoprecipitates were blotted with the 
anti-HA HRP antibody, only two bands appeared for HA-MAT-Ubzl between 50 and 75 
kDa (Figure 4.20, lower panel, lanes 8-9), suggesting that T7-Pl interacts only with the 
full length Ubz 1 and not with its degraded forms. 
A portion of the samples were purified with the anti-HA beads and eluted with the 
HA peptide. When the immunopurified complexes were blotted with the anti-T7 HRP 
antibody, I noticed that the band corresponding to T7-PI was detectable when T7-PI was 
co-transfected both with the HA-MA T-Ubz 1 SprT double mutant (Figure 4.20, upper 
panel, lane 6) and with the HA-MAT-Ubzl WT (Figure 4.20, upper panel. lane 5). 
Additionally, the smear of T7 -PI was stronger when '1'7-PI was co-transfected with the 
SprT double mutant (Figure 4.20, upper panel. lane 6) then when co-transfected with WT 
Ubzl (Figure 4.20, upper panel, lane 5). 
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Figure 4.20. Change in T7-Pl level expression. 2 ~g of T7-P I was co-transfected with 9 ~g of both HA-MAT -Ubz I 
WT and HIIILlE I12A mutant. Samples were purified with the anti-T7 or anti-HA beads. Immune-complexes were 
blotted first with the anti-T7 HRP antibody and then with anti-HA HRP antibody. Lysates blot is shown in lanes 1-3 . 
4.5. Role ofUbzl in DNA Damage 
Given the results that showed PI activated a DNA damage signal (Figure 4.12) and 
that the SprT domain of UbzI is playing a role in regulating PCNA ubiquitination, I 
decided to check ifUbzI could also affect the level of the signal for DNA damage induced 
by PI expression. Therefore, I co-transfected T7-PO, T7-PI and T7-P4 with an empty 
vector, HA-MAT-UbzI or the double SprT mutant HIIILlEII 2A and I blotted the lysates 
with the anti-yH2AX antibody. As shown in Figure 4.21 (panel A), I detected a strong 
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band of yH2AX when T7-PO or T7-PI was co-transfected with the empty vector (lane 2 
and 3), whereas the intensity of that band decreased when T7-PO or T7-PI was co-
transfected with HA-MA T-UbzI WT (lane .5 and 6). Moreover, yH2AX was detected as a 
weak band when T7-P4 was co-transfected \vith the empty vector. which could only be 
seen in a long exposure (not shown) and the intensity of the band decreased when T7-P4 
was co-transfected with HA-MAT-Ubzl WT (lane 7 and long exposure. not shown). 
Importantly, the intensity of the yH2AX band increased when the three T7-PCNA 
constructs were co-expressed with HA-MAT-lJbzI (lflIlLlEI12A). as shown in lanes 8-
10 and in particular it was very high in the case of T7-P I, almost reaching the same levels 
as the HEK293T cells treated with UV that I used as a positive control (lane 11). These 
data indicate that the SprT domain supresses the DNA damage signal caused by PI 
expression. In order to check the level of yl12AX when HA-MAT-Ubzl was expressed 
alone, I transfected HA-MAT-Ubzl WT. D47JA and IIIIILlEl12A in HEK293T cells 
and I blotted the lysates with the anti-yH2AX antibody. As shown in Figure 4.2 L the 
intensity of the bands detected in the HA-MAT-lJbzl WT (lane 2) and HIIILlEl12A 
(lane 4) were quite similar, whereas the band detected for UBZ domain mutant (lane 3) 
was weaker. These results showed discrepancies with the results shown in figure 4.21 
(panel A). For example UbzI WT appeared to decrease the level of the signal for DNA 
damage induced by PI expression, we would expect that the intensity of the band detected 
for WT was weaker than in the Sprt double mutant. To further investigate this ditTerence. 
additional experiments using other DNA damage marker need to be performed. 
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Figure 4.21. Level ofyH2AX upon T7-PCNA constructs and HA-MAT-Ubzl co-transfection. Panel A: T7-PO, T7-
PI and T7-P4 were co-transfected with the empty vector, HA-MAT-Ubz l WT or HIIILfEI12A mutant. Lysates were 
blotted with the anti-yH2AX antibody (first panel) and with anti-HA-HRP and anti-T7 HRP antibodies to check the 
expression of HA-MA T -Ubz I and T7-PCNA, respectively. The asterisk indicates the lower part of the anti-T7 HRP blot 
that shows the T7-Ub cleaved from T7-Ub-PCNA (T7-PI). Anti-GAPOH was used as a loading control. Panel B: HA-
MA T-Ubz I WT, 0473A and H III LIE 112A were expressed in the HEK293T cells and Iysates were blotted with the anti-
yH2AX antibody. Anti-HA HRP was used to check HA-MAT-Ubz l constructs expression and anti-GAPOH was used as 
a loading control. 2SPRT: H III LfE I1 2A. 
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4.6. Conclusions 
In my thesis work, I have shown that Ubzl is a novel protein of UBZ family and 
that the HExH motif in its SprT domain might act as a metalloprotease. In particular, I 
have shown that Ubzl binds unmodified and modified PCNA and the modified form is 
predicted to be PCNA ubiquitinated at the Lysine 164. The three PCNA fusion proteins 
that I built, allowed me to determine that during the co-purification of Ubzl with the 
tagged-ubiquitin-PCNA fusion proteins, the mono-ubiquitinated fusion protein was 
cleaved in two parts, giving rise to tagged ubiquitin and free PCNA, and this appeared to 
happen only to the tagged-ubiquitin-PCNA that interacts with Ubzl. Moreover, I have 
shown that Ubzl appeared to cleave itself in an SprT domain-dependent fashion, as the 
SprT mutant no longer showed degradation bands. The same SprT mutant also had a 
different etIect on tagged-ubiquitin-PCNA expression and when they were co-purified, the 
PCNA fusion protein was no longer cleaved hut appeared as a smear of PCNA. More 
detailed conclusions will be treated in the next chapter. 
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5. DISCUSSION 
DNA damage repair IS an important cellular pathway that must be regulated 
properly in order for chromosomal integrity to be maintained. The proliferating cell 
nuclear antigen, peNA, is critical for the regulation of these repair pathways. PCNA 
tethers replicative polymerases onto DNA. thereby acting as a sliding clamp. In addition to 
tethering replicative polymerases, PCNA also recruits numerous other proteins, including 
Ubzl, to the replication fork and to sites of DNA damage repair. 
During the S phase of the cell cycle, the genome is especially vulnerable and many 
kinds of lesions hamper replication fork progression. If the DNA replication does not re-
start, the replication fork collapses, leading to DNA double strand breaks and genetic 
instability. To prevent this, cells have evolved a particular pathway known as the DNA 
damage tolerance pathway, which allows the replication of the DNA past the lesion. The 
DNA damage tolerance pathway is error prone since the damage is left behind, to be 
repaired at a later time. In particular, when the replication fork encounters DNA damage. 
the replication fork stalls and PCNA can be mono-ubiquitinated at a single residue, K 164, 
leading to an error prone pathway (trans lesion synthesis), or poly-ubiquitinated with a K63 
linked poly-ubiquitin chain. Poly-ubiquitination of PCNA results in the use of a more error 
free pathway (Boege et aI., 2002). LJbzl contains a PIP box and an ubiquitin binding 
domain, so it is strongly recruited to ubiquitinated PCNA. 
5.1. Ubzl is a Novel UBZ Family Protein 
Previously, my lab attempted to identify effectors of the ubiquitin ligase BRCA L a 
gene that is mutated in most inherited forms of breast cancer. BRCA 1, a protein that is also 
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involved in DNA repair, produces a chain of ubiquitin molecules linked via Lysine number 
6 (K6) (Wu-Baer et aI., 2003). In a proteomics screen to identify effectors of BRCA I, my 
lab analyzed proteins that bind and/or arc modified by K6 poly-ubiquitin chains and 
detected WHIP, whose yeast homolog has previously been annotated as functioning in 
DNA damage repair (Hishida et aI., 2001). Further studies on WHIP. revealed that it 
contains an ubiquitin binding domain, annotated as Ubiquitin Binding Zinc finger domain 
or UBZ domain (Bish and Myers, 2007). Interestingly, the UBZ domain appears to be 
specific to the DNA replication and repair process, as all UBZ domain-containing proteins 
have been annotated to play this role in the cel\. UBZ domains have been hypothesized to 
coordinate DNA repair activities by recruiting l lBI family proteins to the replication fork 
through an interaction with ubiquitinated PCNA or other ubiquitinated proteins at the point 
of DNA damage. The UBZ domain therefore appears have a specialized role in DNA 
repair. as opposed to a generalized ubiquitin binding function. Searching a sequence 
database for the proteins that contain a UBI domain, my group also identified the protein 
CIORF124 as a novel UBZ domain containing protein, which was called Ubzl. Ubzl is a 
55 kDa protein with three annotated domains: a peNA interacting motif, an SprT domain 
and a UBZ domain (Centore, Yazinski et al. 2(12). The function of the SprT domain is 
unknown. It carries a conserved metalloprotease IIExH motiC but no eukaryotic SprT 
domain proteins have been characterized. 
In addition to their UBDs, a number of proteins involved in DNA damage repair 
pathway interact with PCNA through a second ubiquitin-independent contact, which 
presumably increases the affinity and specificity for the binding. As Ubzl also contain a 
highly conserved PIP box motif and a UBI domain, I thought that Ubzl also might be 
involved in DNA damage response. 
I have investigated various aspects of Ubz 1 as the main focus of my thesis studies. I 
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started my studies to determine if Ubz I. as has been reported for other UBZ domain 
containing proteins. is subjected to a UBZ domain-dependent ubiquitination. known as 
coupled ubiquitination (Bish et al.. 2008; I [oeller et al.. 2006). Coupled mono-
ubiquitination may have an inhibitory effect. resulting in the intra-molecular interaction 
between the UBZ domain and ubiquitin. As a matter of fact, mono-ubiquitination of POLll, 
in the absence of DNA damage, inhibits the interaction between POLll and PCNA during 
replication. Upon UV damage. reNA is ubiquitinated and POL'll is de-ubiquitinated. 
POLll is now in an open conformation and can bind PCNA (Bienko et al.. 2010). 
[n my thesis work, I demonstrated that. Ubzl is ubiquitinated. To characterize this 
post-translational modification, [ performed a Denaturing-Tandem Affinity Purification 
(DT AP), which consists of a non-denaturing immunoprecipitation. followed by a 
denaturing purification; in this way, [ detect only covalently attached ubiquitin. In fact. 
Ubzl appeared as a smear, whereas the lJBZ domain mutant ran as a single. non-
ubiquitinated band (Figure 4.2). I initially tried to characterize the Ubzl ubiquitination 
with anti-ubiquitin antibodies, but unfortunately I only detected the heavy and light chains 
of the antibody, but not the smear of ubiquitinated Ubzl. The experiment was repeated 
several times changing the conditions, but all my attempts failed and it is unclear why 
these experiments did not work. One possibility is that the detection of ubiquitinated 
proteins can be difficult depending on the amount and type of ubiquitin chain that is 
formed (Swerdlow et aI., 1986). Since the analysis of proteins by mass spectrometry 
allows for the direct observation of post-translational modifications, I decided to make use 
of LC-MS/MS to confirm that the smear in the anti-I [A blots of Figure 4.2 was caused by 
ubiquitination. Comparing the total number of peptides obtained from the mass-
spectrometry analysis, I found a higher number of ubiquitinated peptides in the Ubzl WT 
immunopurification then in the UBZ domain mutant Crable 4.1). In this way. [ was able to 
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prove that Ubzl is ubiquitinated and that this ubiquitination is dependent on its UBZ 
domain. In particular, mass spectrometry of these samples resulted in the identification of 
four Lysine residues that undergo ubiquitination (Figure 4.4) and all four sites are located 
between the PIP box motif and the UBI, domain of Ubzl sequence. I thought that this 
particular arrangement might influence the hinding capacity of the UBZ domain and the 
PIP box, but further experiments need to he performed in order to prove this. These results 
were further strengthened when I analyzed the immunopurified and peptide-eluted UbzI 
WT and UBZ mutant, with the a-ubiquitin antibody. In this way, I was finally able to 
detect a smear of ubi quit ina ted UbzI as shown in Figure 4.3. 
My lab previously demonstrated that WIIIP is subjected to a UBZ-dependent 
covalent poly-ubiquitination (Bish et aL 20(8). The lJhzl smear could correspond to the 
multiply-mono-ubiquitinated or to a poly-uhiquitinated form of UbzI; since I found 
ubiquitin peptides corresponding to K48 in the lJbzl WT sample, I thought that the smear 
might correspond to K48 linked poly-ubiquitinated UhzI rather then to multiply-mono-
ubiquitinated Ubzl. My hypothesis was supported by the fact that more Ubzl was 
ubiquitinated upon treatment with the proteasome inhibitor, as shown in Figure 4.5. 
Therefore the evidence indicates that UbzI undergoes coupled poly-ubiquitination and this 
coupled ubiquitination requires a functional lJBZ domain. In this regard, the coupled 
ubiquitination of UbzI is similar to that observed for other UBZ domain containing 
proteins, such as WHI P. These results were quite consistent with the data recently 
reported, in which demonstrated that when Uhzl (Spartan) was purified in denaturing 
conditions, it ran as a doublet with the upper hand corresponding to ubiquitinated Uhzl 
(Centore et ai., 2(12). 
These data demonstrate that Ubzl possesses a functional UBZ domain. As a matter 
of fact, I showed that the substitution of the Aspartate residue in the UBZ domain of Ubzl 
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is sufficient to reduce the ubiquitin binding of Ubz1. In fact, as previously discussed, mass 
spectrometry analysis revealed a larger number of ubiquitin peptides in the Ubz l WT 
purification than in the UBZ mutant (34 versus 5 total peptides), Table 4.1. Therefore, my 
data demonstrated that the UBZ domain mutant no longer interact with ubiquitin. Based on 
this evidence I established that Ubzl is a novel UBZ domain containing protein and that its 
UBZ domain binds ubiquitin. 
5.2. A Physical Interaction Between Ubzl and PCNA 
The hypothesis that UBZ family proteins are recruited to sites of DNA damage by 
binding ubiquitinated PCNA is strengthened by the observation that most of these proteins 
also physically interact with PCNA. Three different peptide sequences have been found 
that permit other proteins to interact with PCNA. Many proteins that possess a UBZ 
domain, including POLll and POLK, bind PCNA through their PIP box. Ubzl contains an 8 
amino acids long PIP box (325-332 residues), close to the C-terminal end of the protein 
sequence (Figure 5.1). 
PIP UBZ4 
C 
Figure 5.1. Cartoon of Ubzl. The N-tenninal SprT domain is represented in blue, C-tenninal UBZ4 in green and the 
PIP box in grey. 
As part of my thesis, I demonstrated that PCNA interacts with Ubzl. Moreover, a 
second, higher molecular weight PCNA band also immunoprecipitated with Ubzl. This 
band was consistent with the predicted molecular weight of mono-ubiquitinated PCNA. 
Although PCNA is ubiquitinated upon DNA damage, it has been reported that a portion of 
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PCNA is constitutively mono-ubiquitinated even in absence of DNA damage in different 
cell lines, including the HEK293T cells that I used in my experiments (Chiu et al., 2006). 
Unfortunately, with the anti-ubiquitin antibody I vv'as not able to confirm that that upper 
band of PCNA corresponded to its ubiquitinated fom1, but when I digested the 
immunoprecipitated HA-MAT-Ubzl WT with trypsin and I analysed the sample by mass 
spectrometry, I found that PCN A was ubiquitinated at K 164. Moreover. the finding that 
the UBZ mutant did not immunoprecipitate the upper band, suggested that it might be 
ubiquitinated PCNA. My data were consistent with the results reported by Zou's group, 
which shown that Ubzl interacts with both the unmodified and more weakly with a 
modified form of PCNA, even in the absence of DNA damage (Centore et al., 2012). 
Moreover, they built a PIP box mutant. which when compared to the Ubzl WT showed a 
decreased interaction with the unmodified PCNA, but not with its modified form, since it 
has an intact UBZ domain (Centore et al., 2012). 
To gain further insights into the dependence of the interaction of Ubzl with mono-
ubiquitinated PCNA, I also purified the Ubz 1 SprT double mutant and I have shown by 
LC-MS/MS that PCNA was not ubiquitinated at residue K 164, as happened in the case of 
the WT. So, although neither I, nor the other authors that have recently characterized 
Ubz 1, directly detected the ubiquitination of PCN A with a-ubiquitin antibodies. my data 
suggested that the upper band of PCNA is the ubiquitinated form of PCNA at K 164. 
5.3. A Possible Role for SprT Domain 
The SprT domain (amino acids 45-212) of lJbzl has an unknown function. but 
since it posses a HExH motif I thought that it might function as a metalloprotease. In the 
HExH motif, the two Histidine residues are ligands of a zinc atom. and the Glutamate 
residue has a catalytic role. The fourth ligand is a molecule of water that when activated, 
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mediates the nucleophilic attack on the peptide bond. 
In my thesis work, I provided evidence that SprT might be a functional 
metalloprotease. These results were obtained using western blot analysis (Figures 4.8. 
4.13,4.14) and mass spectrometry (Figures 4.7. 4.15, 4.17, 4.18). First, I have shown that 
Ubzl degradation requires its own SprT domain. As a matter of fact. Ubzl ran in western 
blots as multiple bands and mass spectrometry analysis revealed that the band around 55 
kDa contained peptides that covered the entire sequence of Ubz I but surprisingly. the 
lowest portion of the gel contained peptides from the ('-terminal end of Ubzl. Sinee Ubzl 
had a I-IA tag at the N-terminal, the fact that I found peptides that belonged to the opposite 
terminus of the protein indicated that Ubzl might cleave itself during purification. as 
shown in Figure 5.2. This hypothesis was strengthened by further western blot experiments 
that I performed on lJbzl where I mutated the lIistidine and the Glutamate of the SprT 
domain at positions III and 112, respectively. In fact, the SprT domain with a single 
mutant residue showed a decrease in the number of degradation bands, whereas the double 
mutant had virtually no degradation. shown in Figure 4.8. Therefore, the SprT domain is 
likely to be mediator of the Ubzl cleavage, as shown in Figure 5.2. 
109 
HA 
55 kDa N C 
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Figure 5_2_ SprT domain mediating Ubzl autocleavage. The cartoon indicates that the SprT domain of Ubzl appears 
to mediate the Ubzl autocleavage. The HA-MAT-Ubzl bands between 37 and 50 kDa showed a large amount of 
peptides that covered the N-terminal portion of the protein, instead the band around 20-25 kDa surprisingly contained 
peptides coming from the C-terminal ofHA-MAT-Ubz l , indicating that the SprT domain might act as a metalloprotease. 
Furthermore, the SprT domain also plays a role in the interaction between UbzI 
and the ubiquitin-PCNA fusion protein. In fact, I showed that when the three PCNA fusion 
proteins tag-PCNA (PO), tag-Ub-PCNA (PI) and tag-4Ub-PCNA (P4) were co-expressed 
with UbzI , PI was cleaved giving rise to the tagged-ubiquitin and "free" PCNA, as seen in 
Figure 5.3. 
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Figure 5.3. Ubzl mediating HA-MAT-Ub-PCNA cleavage. SprT domain of Ubzl might mediate the cleavage of HA-
MAT-Ub-PCNA, giving the HA-MAT-Ub and the PCNA. 
Given the fact that mutating the putative metalloprotease signature of the SprT 
domain blocks both the cleavage ofUbzl and of PI, I believe that my data indicate that the 
SprT domain functions as a metalloprotease and the possible role of this domain during 
UbzllPCNA expression and purification is illustrated in Figure 5.4. In this case, when the 
SprT double mutant was co-expressed with PI and the SprT domain was not able to cleave 
any of the ubiquitin molecules bound to PCNA, PCNA remained poly-ubiquitinated 
(Figure 5.4) and appeared as a high molecular weight smear in the blot, Figure 4.19. In this 
manner Ubzl was acting as a de-ubiquitinase. 
SPRT PIP UBZ4 
HA MAT UB 
Figure 5.4. HA-MAT-Ub-PCNA poly-ubiquitination with Ubzl SprT double mutant. The cartoon indicates that 
when the SprT domain ofUbzl is mutated and no longer able to remove the ubiquitin bound to the HA-MAT-Ub-PCNA, 
HA-MAT-Ub-PCNA remains poly-ubiquitinated. 
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Furthermore, Ubzl interacts with peNA through both its PIP box motif and the 
UBZ domain, with the UBZ domain binding to the ubiquitin attached to K164 ofPCNA. A 
functional SprT domain at this point would play its role as a metalloprotease, and removed 
any extraneous ubiquitins that have been attached to PCNA. Ilowever, the ubiquitin at 
K 164 was be protected by the UBZ domain and was not be removed (Figure 5.5. panel A 
and Figure 4.9, panel A, lane 2 and panel B. lane I). In this manner, Ubzl is acting as a 
fidelity factor for peNA ubiquitination. Most likely, the PIP box also plays a role in 
directing the binding of the UBZ domain oflJBZI to KI64 ofPCNA. 
In the case where the UBZ domain mutant was expressed, Ubzl interacted with 
peNA only through its PIP box motif. The SprT domain was able to cleave all the 
ubiquitin molecules bound to PCNA, including those at Lysine 164 of PCNA (Figure 5.5, 
panel B). As a matter of fact, in the western blots I saw only one band for PCNA that 
immunoprecipitated with Ubzl, which corresponds to the unmodified form of peNA 
(Figure 4.9, panel B, lane 2). 
In the case of the SprT double mutant lJbzl was no longer able to act as a 
metalloprotease and I did not detect any band of peNA co-immunoprecipitating with Ubzl 
(Figure 4.9, panel A, lane 3 and panel B, lane 4). I proposed that the non-functional SprT 
domain allowed all the ubiquitins to remain on peNA and that this poly-ubiquitinated 
peN A underwent rapid degradation (Figure 5.5. panel C). The single mutant in the SprT 
domain retained some protease activity and was able to de-ubiquitinate a portion of peN A 
and kept it from being degraded (Figure 5.5, panel D and 4.9, panel B, lane 3). 
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Figure 5.5. Model proposed for SprT domain role. Panel A: Ubz l WT. PIP box binds PCNA. The UBZ domain 
protects the ubiquitin bound to KI64 of PCNA from SprT cleavage. Panel B: UbzI UBZ mutant. PIP box binds the 
PCNA. The UBZ domain cannot protect ubiquitin bound to KI64 of PCNA from SprT cleavage. Panel C: Ubzl SprT 
domain double mutant. PIP box binds the PCNA. SprT domain cannot cleave ubiquitins bound to the PCNA. Panel D. 
Ubzl SprT single mutant. PIP box binds the PCNA. SprT domain partially cleaves ubiquitins bound to the PCNA. 
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In summary, my thesis work indicates that Ubzl contains a functional UBZ domain 
and that like other UBZ domain containing proteins, Ubzl undergoes coupled 
ubiquitination. Ubzl also contains an SprT domain that appears to encode a functional 
metalloprotease that functions to cleave Ubz 1 and to de-ubiquitinate PCNA. Interestingly, 
the UBZ domain and the SprT domain function together as a tidelity factor. which results 
in PCNA being ubiquitinated only at K 164. This is due to the UBZ domain binding and 
protecting the ubiquitin attached to K 164 and the SprT domain removing the other attached 
ubiquitin molecules. The autocleavage of Ubz 1 either occurs as an artefact of puritication 
or may also play a regulatory role. Importantly. my data reveal a previously unknown 
mechanism regulating the ubiquitination ofPCNA. 
5.4. A Possible Role for Ub-PCNA (PI) and Ubzl 
As previously described, when replicative polymerases encounter DNA damage. 
they stall because they are not able to accommodate bulky lesions or mismatched bases. As 
a consequence, PCNA is mono-ubiquitinated and the translesion polymerases (TLS POL). 
which have a major affinity for mono-ubiquitinated PCNA. replace the replicative 
polymerases. Once the TLS POL replicate past the damage. peNA is de-ubiquitinated by 
USPI. Therefore, PCNA is mono-ubiquitinated as a consequence of DNA damage, leading 
to translesion synthesis, which does not repair the lesion but rather bypasses the damage. 
Consequently, the DNA damage persists and it may be detected by the cell machinery. 
which results in the activation of the ATM/ ATR signalling pathway. ATM/ ATR 
phosphorylate different substrates, including CIIK I. CIIK2 and yH2AX. This pathway 
might be an explanation of why PI expression increases the level of yH2AX, as shown in 
Figure 4.12. Another possibility might be that P I is being considered as a signal of damage 
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itself, even in absence of any real DNA damage and as a consequence PI activates 
A TMI A TR signalling, resulting in the increased levels of yH2AX. 
Ubzl appears to be functionally linked to peNA. In fact, it has been recently 
reported that Ubz I is principally expressed during Sand G2 phase of the cell cycle 
(Mosbech et aI., 2012), which is also the phase of the cell cycle where PCN A mainly 
exerts its function. Moreover, my preliminary data obtained from cyclohexamide 
experiments, suggested that Ubzl is present in two different pools in the cell. one 
undergoing rapid degradation and one undergoing slower degradation. The blot in Figure 
4.20 shows that only the full-length lJbzl. but not the degradation products, 
immunoprecipitated with the Ub-PCNA (PI) suggesting that peNA may be a stabilization 
factor for Ubzl. In this way, the pool of Ubzl that was rapidly degraded would represent 
the free pool of UbzL whereas the Ubzl that was slowly degraded, would be the pool 
bound to PCNA. 
Ubzl also appeared to act as a de-ubiquitinase. It has been reported that the USP! 
de-ubiqutitinase autocleaves itself upon UV damage, recognizing an ubiquitin-like di-
glycine (GG) motif in its own sequence (I luang et aI., 2006). The initial goal of the 
analysis of Ubzl degradation bands had been to detect if the final amino acids of the 
peptides contained in the lower bands matched \\ ith the di-glycine (GG) motiC but that 
was not the case. Since if a lesion is not repaired during the S phase of the cell cycle, the 
replication fork may collapse leading to a douhle strand break. cells have developed the 
TLS mechanism in order to replicate past the damage. Mono-ubiquitinated peNA has a 
key role in recruiting TLS polymerases to the site of the stalled fork and my data suggested 
that Ubz I appeared to ensure PCNA mono-ubiquitination at the K 164. In particular. the 
PIP box and the UBZ domain of Ubz I are necessary for a correct positioning of the protein 
for its interaction with the mono-ubiquitinated peNA (Figure 5.5, panel A) and the SprT 
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and the UBZ domain together collaborate to maintain the peNA being mono-ubiquitinated 
specifically at K 164. As a matter of fact, the SprT domain cleaves all the ubiquitin bound 
to the PCNA except at K 164, which is protected by the UBZ domain. These data were 
consistent with recent results in which it was demonstrated that upon Ubzl knockdown. in 
case of UV, there was a decrease of the recruitment of polymerase T] at the site of the 
damage (Centore et aI., 2012). Thus, Ubz 1 appears to be important for the recruitment of 
TLS polymerase at the site of the stalled fork. promoting a damage bypass and avoiding 
the collapse of the replication fork with more dramatic consequences. 
Recently, several labs have characterized Ubzl. In particular, Ubzl has been found 
to be involved in single strand DNA damage response (Centore et aI., 2012; Davis et al.. 
2012; Ghosal et aI., 2012; Juhasz et ai., 2012; Machida et aI., 2012; Mosbech et ai., 2012). 
The UBZ domain was found to be important for the localization of Ubzl to the sites of 
DNA damage, but there are some discrepancies in this regard. For example, it is not clear 
if the mono-ubiquitination of PCNA is dispensahle for the recruitment of Ubzl to the sites 
of the DNA damage. In this regard. upon the lJV treatment. even in case of knockout of 
Rad 18, Ubzl appeared to be recruited to the damage foci. Two groups hypothesized that 
Ubzl is recruited to the sites of damage by other ubiquitinated factors (Davis et ai., 2012. 
Mosbech et ai., 2012). In addition, Ubzl seems to have an effect on PCNA mono-
ubiquitination, but the data in this case are not in agreement. In particular. upon Ubz I 
knockdown, following lJV damage, mono-ubiquitination of PCNA descreses, leading to a 
minor recruitment of polymerase T] at the sites of damage (Centore et ai., 2012). but these 
data are not consistent with two more recent papers that report that following UV damage 
and Ubzl knockdown, the PCNA mono-ubiquitination increases and there is a persistence 
of the TLS polymerases at the damage foci. Althought no model proposed by the authors 
seems to be very consistent with my results, Juhasz et al. have recently reported that Ubzl 
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ensures the level of ubiquitination of PCNA and these data appered to support my model 
proposed in Figure 5.5 (Juhasz et aL 2012). Although the role of the UBZ domain and PIP 
box of Ubzl have been characterized, only one group has investigated the Sprt domain 
role. In particular, they show that the Sprt domain of Ubzl appeared to be necessary for 
suppression of damage-induced mutagenesis, but this was only a minor experiment in the 
paper (Kim et aI., 2013). Importantly, my work indicates that the SprT domain is a 
functional protease that works in concert with the UBZ domain to regulate the 
ubiquitination ofPCNA. 
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